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Abstract A paradox is a seemingly absurd or impossi-
ble concept, proposition, or theory that is often difficult
to understand or explain, sometimes apparently self-
contradictory, and yet ultimately correct or true. How
is it possible, for example, that oxygen Ba toxic envi-
ronmental poison^ could be also indispensable for life
(Beckman and Ames Physiol Rev 78(2):547–81, 1998;
Stadtman and Berlett Chem Res Toxicol 10(5):485–94,
1997)?: the so-called Oxygen Paradox (Davies and
Ursini 1995; Davies Biochem Soc Symp 61:1–31,
1995). How can French people apparently disregard
the rule that high dietary intakes of cholesterol and
saturated fats (e.g., cheese and paté) will result in an
early death from cardiovascular diseases (Renaud and
de Lorgeril Lancet 339(8808):1523–6, 1992; Catalgol
et al. Front Pharmacol 3:141, 2012; Eisenberg et al. Nat
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Med 22(12):1428–1438, 2016)?: the so-called, French
Paradox. Doubtless, the truth is not a duality and epis-
temological bias probably generates apparently self-
contradictory conclusions. Perhaps nowhere in biology
are there so many apparently contradictory views, and
even experimental results, affecting human physiology
and pathology as in the fields of free radicals and oxi-
dative stress, antioxidants, foods and drinks, and dietary
recommendations; this is particularly true when issues
such as disease-susceptibil i ty or avoidance,
Bhealthspan,^ Blifespan,^ and ageing are involved. Con-
sider, for example, the apparently paradoxical observa-
tion that treatment with low doses of a substance that is
toxic at high concentrations may actually induce tran-
sient adaptations that protect against a subsequent expo-
sure to the same (or similar) toxin. This particular
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paradox is now mechanistically explained as BAdaptive
Homeostasis^ (Davies Mol Asp Med 49:1–7, 2016;
Pomatto et al. 2017a; Lomeli et al. Clin Sci (Lond)
131(21):2573–2599, 2017; Pomatto and Davies 2017);
the non-damaging process by which an apparent toxicant
can activate biological signal transduction pathways to
increase expression of protective genes, by mechanisms
that are completely different from those by which the
same agent induces toxicity at high concentrations. In this
review, we explore the influences and effects of paradoxes
such as the Oxygen Paradox and the French Paradox on
the etiology, progression, and outcomes of many of the
major human age-related diseases, as well as the basic
biological phenomenon of ageing itself.
Keywords Oxidative stress . Oxygen Paradox . Age-
related diseases . FrenchParadox .Ageing . Proteostasis .
Adaptive Homeostasis . Healthspan
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Basic aspects of the Oxygen Paradox, the French
Paradox, and ageing
Cellular homeostasis is constantly challenged by reactive
oxygen and nitrogen species which are either generated
endogenously during cellular metabolism (e.g., by mito-
chondria, NADPH oxidases, and cytochrome P450
reductases) or originate from exogenous sources including
drugs, xenobiotics metals, and radiation. Reactive oxygen
and nitrogen species alter a wide variety of macromole-
cules including proteins, lipids, sugars, DNA, and RNA.
Depending on the severity of oxidatively generated dam-
age, newly oxidized molecules are repaired or are elimi-
nated by dedicated degradation systems.When production
or clearance of reactive oxygen and nitrogen species is
overwhelming or when repair/degrading systems for dam-
aged molecules are impaired, oxidative stress occurs. Ex-
cessive amounts of (unrepaired) oxidant-induced cellular
damage are associated with cancer, ageing, and numerous
other pathologies such as Parkinson and Alzheimer dis-
eases (Beckman and Ames 1998; Stadtman and Berlett
1997). Thus, the first paradox to be considered in this
discussion is the BOxygen Paradox^—the discovery that
although oxygen is essential for multicellular eukaryotic
life forms, its very chemical/physical nature ensures its
conversion into oxygen radicals, and other reactive oxygen
species, that cause damage to cells, organs, and organisms.
In human terms, it would be very hard to live without
oxygen, but it is also extremely hard to live with oxygen
(Fig. 1) (Davies and Ursini 1995).
The French paradox was proposed in 1992 based on
epidemiological data from the French population (Renaud
and de Lorgeril 1992). Diets with high intakes of dietary
cholesterol and saturated fat were found to coincide with
low rates of coronary heart disease and low risk of cardiac
mortality in the French populace. These findings were
counterintuitive and were aptly dubbed the BFrench
Paradox.^ However, in-depth research has provided new
evidence as to why the BFrench Paradox,^ which seeming-
ly is harmful, may actually promote the health and longev-
ity of the French people. For example, the high consump-
tion ofwine and cheese, both ofwhich are often viewed in a
negative light, may actually be beneficial. Due to wine’s
high concentration of resveratrol (Catalgol et al. 2012),
and the high prevalence of spermidine in cheese
(Eisenberg et al. 2016), the French diet may actually
contribute to the positive effects of the French Paradox.
Clearly, much of what underlies the French Paradox is, in
turn, caused by the BOxygen Paradox^ wherein oxidative
stress is seen as an unavoidable consequence of aerobic
life (Davies and Ursini 1995) and a major contributor to
the initiation and/or progression of many age-related hu-
man diseases.
The goal of this review is to explore new viewpoints that
may help to explain how basic aspects of the Oxygen
Paradox are impacted by the diet and environment and, in
GeroScience (2017) 39:499–550 501
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Fig. 1 Sources of oxidative stress, cellular defenses, and compro-
mised stress resistance with ageing. Upper (green background)
panel—young cells—cells must cope with both internal and ex-
ternal sources of oxidative stress. Extracellular sources include
smoke and partial combustion products (of all forms), pollution,
radiation, environmental toxicants, and various dietary constitu-
ents. One internal source of oxidative stress arises from mitochon-
drial electron transport and respiration. Electron Bleakage^ from
the electron transport chain to molecular oxygen generates super-
oxide (O2
·−) which is either dismutated into hydrogen peroxide
(H2O2) via the mitochondrial manganese superoxide (MnSOD) or
the cytosolic copper-zinc superoxide (CuZnSOD). Additionally, if
the superoxide is not removed and/or an accumulation of hydrogen
peroxide (above homeostatic levels) occurs, the likelihood of
hydroxyl radical (HO·) generation increases, with consequent pro-
tein, lipid, and even DNA damage. To combat these potential
sources of damage, mitochondria rely upon detoxification en-
zymes, such as glutathione peroxidase (GPx) and proteolytic en-
zymes, such as the mitochondrial Lon protease, which can remove
oxidized proteins. Another prominent internal source of oxidative
stress are peroxisomes, which can generate O2
·−, H2O2 (and, thus,
HO·) as a consequence of fatty-acid metabolism. Fortunately, the
O2
·− can be dismutated by CuZnSOD. And the H2O2 can be
removed by catalase which is in extremely high concentration
inside peroxisomes. The endoplasmic reticulum also contributes
to cellular levels of reactive oxygen species, due to H2O2 genera-
tion from protein folding and the formation of O2
·− by membrane-
bound NADPH oxidase (NOX) enzymes. An additional safety
mechanism the cell relies upon is the 20S proteasome. During
periods of oxidative stress, the 19S regulatory caps of the 26
proteasome are sequestered away by HSP70 and ECM29, increas-
ing the available pool of ATP-independent 20S proteasomes.
These free 20S proteasomes can degrade oxidized proteins, thus
preventing their aggregation and cross-linking and providing a
pool of (undamaged) amino acids for the synthesis of additional
protective enzymes. Overall, a combination of protective cellular
mechanismsminimizes damage accumulation and help tomaintain
cellular homeostasis (depicted by the green background). Thus, in
young cells and organisms generally, only a small amount of
damage occurs and most of that is repaired. The green balls inside
the mitochondria represent small amounts of mildly oxidatively
damaged proteins, as do the orange colored balls in the cytoplasm.
In both mitochondria and cytoplasm, the yellow star-bursts indi-
cate severely damaged, aggregated and often cross-linked proteins.
Lower (light red background) panel—old cells—with age, gradual
damage accumulation can lead to less-than-optimal defense sys-
tems. As a result, background inflammation and oxidative stress
can increase from both external and internal sources (symbolized
by the red background). Additionally, the internal generation of O2
·−
and H2O2 may increase, but the enzymatic defenses, such as the
mitochondrial Lon protease or superoxide dismutase may decrease
in clearance efficiency, further exacerbating damage accumulation.
GeroScience (2017) 39:499–550502
turn, affect the etiology and progression of age-related
human diseases.
The role of adaptive homeostasis in the Oxygen
Paradox
The third (apparent) paradox to be considered in this review
is the seemingly paradoxical observation that treatment
with low doses of a substance that is toxic at high concen-
trations may actually induce transient adaptations that pro-
tect against a subsequent exposure to the same (or similar)
toxin. Thankfully, we can nowmechanistically explain this
particular ostensible paradox as the phenomenon of
BAdaptive Homeostasis^ (Eisenberg et al. 2016; Davies
2016; Pomatto et al. 2017a; Lomeli et al. 2017; Pomatto
and Davies 2017),;the non-damaging process by which an
apparent toxicant can activate biological signal transduction
pathways to increase expression of protective genes, by
mechanisms that are completely different from those by
which the same agent induces toxicity at high concentra-
tions. Adaptive pathways allow cells and organisms to cope
with transient environmental and internal perturbations. It is
now clear that resistance to multiple forms of stress is not a
static property of cells, tissues, or organisms. Indeed, mul-
tiple protective systems demonstrate great transient plastic-
ity in response to very small changes in reactive oxygen
species, such as the superoxide anion radical (O2
·–) and
hydrogen peroxide (H2O2). The term Adaptive Homeosta-
sis describes this important cellular capability. Single or
repeated exposures to mild stress at younger ages are
beneficial against higher, more toxic oxidant levels, indi-
cating that rescue systems are actively induced in the young
(Eisenberg et al. 2016; Davies 2016; Pomatto et al. 2017a;
Lomeli et al. 2017; Pomatto and Davies 2017). Adaptive
Homeostasis has been defined as follows: BThe transient
expansion or contraction of the homeostatic range in re-
sponse to exposure to sub-toxic, non-damaging, signaling
molecules or events, or the removal or cessation of such
molecules or events.^ This definition allows us to predict
and explain the transient expansion of the homeostatic
range that occurs upon exposure to nanomolar, even
picomolar, levels of agents that would only be damaging
or toxic in the millimolar range. Since a wide variety of
diets, environmental conditions, and human activities (in-
cluding exercise, a pro-oxidant activity) involve both mild
stresses and positive health benefits, there is real hope that
new strategies relying on adaptive homeostatic effects
could be used as palliative or preventive agents in human
beings (Rattan and Le Bourg 2014).
The importance of adaptive homeostasis, and its decline
with age, can be seen in two studies conducted in the fruit
fly Drosophila melanogaster. Proteasome, a protease in-
volved in the degradation of both normal ubiquitinylated
proteins and mutated or damaged proteins, regulates a vast
number of cellular functions (Bonet-Costa et al. 2016;
Johnston-Carey et al. 2015). Impaired proteasome function
promoted several Bold-age^ phenotypes and markedly re-
duced the lifespan of flies (Tsakiri et al. 2013a, b; Pomatto
et al. 2017b). Proteasome expression is regulated by the
NFE2-related factor 2 (Nrf2)/Ketch-likeECH-associated
protein 1 (Keap1) signaling pathway. This pathway and
its constituent components (i.e., the Nrf2 ortholog, cap’-n’-
collar isoform-C (CncC), and the Keap1 and Maf proteins)
are conserved in Drosophila and appear to engage in
similar regulatory interactions as in vertebrates (Sykiotis
and Bohmann 2008). The Nrf2 pathway works well in
young flies, where it induces proteasome expression and
increased oxidative stress resistance. This important mech-
anism of adaptive homeostasis is severely abrogated in old
age. Interestingly, inducible activation of Nrf2 in transgenic
flies upregulated basal proteasome expression and activity,
independently of age and conferred resistance to
proteotoxic stress. Prolonged Nrf2 overexpression, howev-
er, reduced longevity indicating that excessive activation of
the proteostasis pathways can be detrimental (Fig. 2)
(Tsakiri et al. 2013b).
Another cellular stress-responsive protein is the mito-
chondrial Lon protease. Lon is a major regulator of mito-
chondria physiology, regulating and chaperoning imported
proteins into the mitochondria and degrading unfolded,
oxidized, and non-assembled proteins. Acute stressors such
Similarly, the defense enzymes necessary to protect against per-
oxisome and endoplasmic reticulum O2
·−and H2O2 generation
may decrease in efficiency with age, together leading to a cellular
imbalance toward oxidative damage. Finally, the 20S proteasome
must deal with more and more oxidized proteins (indicated by a
great increase in green and orange balls, and yellow star-bursts
compared with the upper panel of young cells), many of which
aggregate and cross-link before they can be degraded. This results
in proteasome becoming irreversibly bound to ‘clumps’ of dam-
aged proteins that it cannot degrade. Proteasomes bound to such
oxidized protein aggregates (sometimes called lipofuscin) become
inactive, thus further decreasing clearance of damaged proteins
and enabling ever-increasing protein aggregation
GeroScience (2017) 39:499–550 503
as heat shock and oxidative stress lead to its up-regulation
(Ngo et al. 2013; Pinti et al. 2010, 2011, 2016). However,
prolonged oxidative stress can cause Lon down-regulation
(Pinti et al. 2015). A new study by Pomatto et al. (Pomatto
et al. 2017c) showed that young female fruit flies (but not
males or old flies) were capable of H2O2 stress adaptation
and increased Lon expression, whereas only young males
were capable of paraquat stress adaptation and adaptive
increase in Lon expression. These results suggest both an
age- and sex-dependent threshold for transient oxidative
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Fig. 2 Adaptive homeostasis and nrf2 dependent stress responses
decline with age. During cellular homeostasis in young organisms
and tissue, nuclear factor (erythroid-derived 2)-like 2 (Nrf2), the
master stress-responsive transcriptional activator, is retained in the
cytosol bound to the Keap1-Cul3 complex, which contains a
ubiquitin E3 ligase. In the absence of stress in young cells (top
left panel) Nrf2 is polyubiquitinylated, tagging it for degradation
by the ATP-dependent 26S Proteasome, and preventing Nrf2
translocation into the nucleus. Concurrently, as the Nrf2 protein
undergoes rapid turnover, the nrf2 gene is constantly transcribed
and translated, and de novo Nrf2 is bound to Keap1-Cul3 com-
plexes, enabling cells to have a constant supply of Nrf2. At the
same time, cells retain sizeable pools of both 20S and 26S forms of
the Proteasome for (different forms of) protein clearance. During
periods of oxidative stress in young cells (top right panel), Nrf2 is
released from the Keap1-Cul3 complex and phosphorylated, and
then translocated into the nucleus. Once in the nucleus, Nrf2 binds
to the antioxidant response element (ARE), also called the elec-
trophile response element (EpRE), leading to the transcriptional
upregulation of stress responsive enzymes, including the 20S
Proteasome. With age, however (bottom left panel), the ability to
mitigate damage declines, resulting in an overall increase in base-
line inflammation (symbolized by the pink background). In addi-
tion, the pool of available Proteasomes (both 20S and 26S) is
diminished, as a certain percentage become inactive after binding
to indigestible protein aggregates. The inability to clear away all
cellular damage promotes the accumulation of protein aggregates,
thus further diminishing the available pool of Proteasome. During
periods of acute stress in aged cells (indicated by the darker pink
background in the bottom right panel), cellular limitations of the
stress-response system become evident, as binding of Nrf2 to
ARE/EpRE sequences diminishes. Decreased binding efficiency
of Nrf2 to ARE/EpRE sequences may be due to Nrf2 competitors
such as c-Myc and Bach1. The net result is significantly decreased
ability to rapidly upregulate target stress-responsive genes, further
promoting protein aggregation, diminished proteostasis, and inef-
fective adaptive homeostasis
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stress adaptation, including increased Lon expression, that
is beneficial for survival of a short stress, but costly for
longevity. Thus, the balance of positive and negative effects
of adaptive homeostasis on fitness traits could vary. Further
investigation is necessary to determine what conditions/
treatments might ultimately lead to beneficial therapeutic
interventions for humans.
A novel family of peptides, encoded within the
mtDNA, has been shown to normalize mitochondrial
function and to prevent metabolic deterioration, vascu-
lar disease, diabetes, and neurodegeneration, namely the
mitochondrial-derived peptides, humanin (Yen et al.
2013), MOTS-c (Lee et al. 2016a), and SHLPs (Cobb
et al. 2016). These mito-hormones hold promise as both
diagnostic and therapeutic agents in human disease and
their role in the paradox is being studied.
The aged proteome and decline of adaptive homeostasis
in ageing
Dysregulation of protein homeostasis and accumulation of
oxidatively modified proteins by reactive oxygen/nitrogen
species and various processes related to the formation of
advanced glycated/lipid peroxidation end products (AGEs
and ALEs) are hallmarks of the ageing process in different
organs and tissues across different species (Stadtman and
Berlett 1997; Baraibar and Friguet 2013). In addition,
cellular protein maintenance systems, such as the protea-
some system, are often themselves affected during ageing
and upon oxidative stress, losing effectiveness over time
(Baraibar and Friguet 2013). Thus, the accumulation of
altered proteins during ageing is due to both an increased
production of modified proteins and a decreased efficacy
of the mechanisms responsible for their removal
(Petropoulos and Friguet 2006).
Among the many types of oxidative protein modifica-
tions described, carbonylation is one of the most promi-
nent. Protein carbonylation is irreversible and often leads
to loss of function or gain of toxic function of the targeted
proteins (Baraibar and Friguet 2013). However, the key
question, whether protein carbonylation is directly in-
volved in ageing and age-related diseases, remains unan-
swered. In recent years, different studies have provided
evidence that the oxi-proteome (the build-up of
carbonylated proteins) during ageing and age-related dis-
eases is composed of only a limited group of proteins
(Baraibar and Friguet 2013), indicating that not all pro-
teins have the same susceptibility for oxidation. For ex-
ample, the replication and differentiation capability of
adult muscle stem cells (satellite cells) is compromised
with age, contributing to the development of sarcopenia.
However, the molecular events related to satellite cells
dysfunction during ageing are not completely understood.
Decline of adaptive homeostasis in mitochondria
Recent evidence indicates that expression of the Lon
protease may be regulated by pro-oxidants in a manner
consistent with the removal of oxidatively modified
proteins (Ngo et al. 2013). An alternative or additional
mode by which Lon may be inactivated or activated in
response to pro-oxidants is through its own modifica-
tion. While free radicals have long been viewed as
damaging species, it is now recognized that, by virtue
of their reversible nature, certain oxidative modifica-
tions to proteins may serve to regulate their function(s).
At the interface between the body and the environment,
the skin is directly exposed to numerous chemical oxidants
and other air pollutants, all of which are potent inducers of
reactive oxygen/nitrogen species (Mancebo and Wang
2015; Valacchi et al. 2012). An in vitro model using a
direct exposure device for studying the cellular effects of
five VOCs (hexane, toluene, acetaldehyde, formaldehyde,
and acetone) at doses mimicking low-dose chronic envi-
ronmental exposure on skin keratinocytes and skin ex-
plants assessed Lon protease activation and degradation
of oxidatively modified proteins induced by VOCs expo-
sure. Exposure of cells or skin explants to VOCS induced
free radical production that mediated apoptosis due to
DNA damage, mitochondrial membrane potential col-
lapse, lipid peroxidation, and proteasome and Lon protease
inactivation in keratinocytes and in human skin explants.
It is well known that proteasome dysfunction is a con-
sequence of oxidative stress and that proteasome inhibition
induces mitochondrial dysfunction (Livnat-Levanon et al.
2014). In keratinocytes, exposed to mild air pollutants, no
induction of Lon expression was observed, suggesting that
the damage was so great that VOC induced irreparable
injuries which did not allow induction of cellular defenses.
Another example assessing the consequence of chronic
oxidative stress relies upon the Parkinson Disease mouse
model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP) intoxication. Bulteau et al. showed that Lon pro-
tease expression increased in the ventral mesencephalon of
intoxicated animals, concomitantly with the appearance of
oxidized proteins and dopaminergic cell loss. In addition,
they reported that Lon protease is inactivated by oxidants
and is not able to cope with the accumulation of oxidized
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proteins produced in the mitochondria. In this case, even
induction of increased Lon expression is not sufficient to
overcome the oxidative insult.
Taken together, these data underscore the importance of
adaptive homeostasis. It is increasingly apparent that pro-
oxidants do not simply cause damage, but can regulate
protein function in a reversible fashion. Thus, critical
factors that shift the balance from non-damaging and
reversible signaling, to oxidative stress and irreversible loss
are major threats to normal function and healthy ageing.
Heart and circulatory system
The term cardiovascular disease (CVD) actually encom-
passes an array of diseases including coronary artery
disease, hypertension, congestive heart failure, and
stroke. Atherosclerosis that begins early in life and
progresses gradually is a major cause of cardiovascular
disease (Madamanchi et al. 2005).
Atherosclerosis
The development of atherosclerosis is a complex process,
involving the interaction of a variety of cells within the
vessel wall, including endothelial cells, trans-differentiated
vascular smooth muscle cells, and monocytes/macro-
phages. These two later cell types are believed to play a
pivotal role in the development of the disease, mainly
through the accumulation of oxidatively modified low-
density lipoproteins (oxLDL, a proatherogenic particle de-
tected in the intima of the arterial wall), and the production
of inflammatory mediators, cytokines, and extracellular
matrix-degrading enzymes (Glass and Witztum 2001). If
left unchecked, will eventually lead to the formation of a
lipid core of advanced atherosclerotic plaques (Tabas 2005).
Fortunately, ATP-binding cassette (ABC) trans-
porters maintain cellular cholesterol homeostasis and
protect arteries from atherosclerosis (Schmitz et al.
2006). High-density lipoproteins (HDLs), lipoproteins-
containing apolipoproteinA1 (apoA1), are the principal
lipoproteins that play a major role in RCT.
HDL particles and their apoA1, recovered from hu-
man atheroma, are extensively oxidized by
myeloperoxidase (MPO) and are non-functional
(Huang et al. 2014). In vitro oxidation of either apoA1
or HDL particles by MPO impairs their cholesterol
acceptor function. In addition, oxindolyl alanine (2-
OH-Trp) moiety at Tryptophan72 (Trp72) of apoA1 is
selectively oxidized byMPO, is markedly enriched with-
in human atheroma, and is functionally inactive, includ-
ing inhibition of the ABCA1-dependent cholesterol ac-
ceptor activity of apoA1. OxTrp72-apoA1 recovered
from human atheroma or plasma is lipid poor, virtually
devoid of cholesterol acceptor activity and demonstrates
both a potent pro-inflammatory activity on endothelial
cells and an impaired HDL biogenesis activity in vivo.
Elevated levels of the MPO-oxidized apoA1 form,
oxTrp72-apoA1, in subjects are thus associated with
increased cardiovascular disease risk, and may serve
for monitoring a pro-atherogenic process in the artery
wall. Their studies also reveal MPO-catalyzed oxidation
of apoA1 as a potential therapeutic target for the treat-
ment and prevention of atherosclerotic heart disease.
Among the antioxidant systems, thioredoxin-1 (Trx-
1), a 12-kDa highly conserved protein, has recently been
recognized as a critical protective system against oxida-
tive stress. Interestingly, this protein decreases dramati-
cally with risk factors (Forstermann 2008). The
C-terminal truncated form made up of 1–80 or 1–84
N-terminal amino acids (Trx-80), both cleaved by two
alpha-secretases (ADAM-10 and ADAM-17) at the cell
surface, possesses a cytokine like activity (Pekkari and
Holmgren 2004). Macrophages have been reported to
cleave Trx-1 to yield Trx-80 (Bizzarri et al. 2005).
In atherosclerosis, Trx-1 polarized macrophages to the
M2 anti-inflammatory phenotype and protected the
ApoE2.Ki mouse against atherosclerosis (El Hadri et al.
2012). Conversely, Trx-80, oriented macrophages toward
the M1-pro-inflammatory phenotype and enhanced ath-
erosclerosis in the same animal model (Mahmood et al.
2013), promotes pro-inflammatory macrophages of the
M1 phenotype and enhances atherosclerosis. Trx-80 also
exerts angiogenic and mitogenic effects (Couchie et al.
2017). In addition, isolated perfused hearts adapted to
ischemia and reperfusion by short cycles of ischemia
and reperfusion (I/R), the protection is apparently
afforded by the enhanced induction of Trx-1 (Turoczi
et al. 2003). Further studies conducted in animal models
suggest that Trx-1 has many beneficial functions in the
heart including a protective role in cardiac hypertrophy
(Matsushima et al. 2011; Yamamoto et al. 2003).
Endothelial and vascular smooth muscle cells (VSMC)
are involved in the vascular ageing and play a major role in
CVD through the endothelial dysfunction and VSMC
transdifferentiation/calcification. The senescent phenotypes
associated with Lamin A/C alterations can be due to muta-
tions in the lamin-encoding gene LMNA resulting in
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familial lipodystrophy FPLD2 associated with early athero-
sclerosis (Bidault et al. 2013), or treatment with some anti-
HIV antiretroviral drug (ART), such as protease inhibitors
(PI) (Lefèvre et al. 2010). These treatments are associated
with increased cardiovascular risk in ageing HIV-infected
ART-controlled patients and alter the processing of
prelamin-A to lamin-A resulting in the accumulation of
farnesylated prelamin-A leading to cell senescence. By
comparing the endothelial function and senescence in pri-
mary human coronary endothelial cells culture issued from
an old and a young individual, old subjects accumulated
prelamin-A and exhibited endothelial dysfunction, oxida-
tive stress, inflammation, and senescence.Most PIs induced
the accumulation of farnesylated prelamin-A, as a result of
their ability to inhibit the enzyme involved in the processing
of prelamin-A to lamin-A, ZMPSTE24 as well as endothe-
lial dysfunction, oxidative stress, inflammation, and senes-
cence. Importantly, statin treatment prevented all those
alterations; other classes of ART molecules, such as
maraviroc or dolutegravir, entry or integrase inhibitors,
respectively, were either not affecting vessels or able to
decrease inflammation and senescence.
Overexpressing mutant LMNA in primary human
VSMC culture or treating them with PIs increased
prelamin-A and decreased ZMPSTE24. Similar results
were obtained in fibroblasts from LMNA-mutated
lipodystrophic patients and peripheral blood mononuclear
cells from PI-treated-HIV-infected patients. These alter-
ations positively correlated with oxidative stress, inflam-
mation, senescence, and calcification. ZMPSTE24 silenc-
ing in native VSMCs recapitulated the mutant LMNA-
and PI-induced accumulation of farnesylated prelamin-A,
oxidative stress, inflammation, senescence, and calcifica-
tion. The farnesylation inhibitors pravastatin and the
farnesyl-transferase inhibitor, FTI-277, or the antioxidant
N-acetyl cysteine, partly restored ZMPSTE24 expression,
and concomitantly decreased oxidative stress, inflamma-
tion, senescence, and calcification of PI-treated VSCMs.
Thus, ZMPSTE24 down-regulation, resulting from
LMNA mutations or PI treatments, should be considered
as a major contributor in VSMC dysfunctions in early
atherosclerosis. Statin and antioxidants could be of thera-
peutic interest in that setting.
VSMC change of phenotype ( i . e . , the i r
transdifferentiaton) contributes to the pathogenesis of age-
related CVD such as atherosclerosis and post-angioplasty
restenosis. Cyclic AMP, the production and degradation of
which are catalyzed by adenylyl cyclases (AC) and phos-
phodiesterases (PDE), respectively, plays a key role in
modulating VSMC phenotype. Additionally,
transdifferentiation of VSMCs into inflammatory/
migratory cells in vitro depends on de novo expression of
the transmembrane AC isoform 8 (Clement et al. 2006).
The pathological VSMCs in human atherosclerosis lesions
have high AC8 levels (Gueguen et al. 2010).
Stroke
Age is a well-documented prominent non-modifiable risk
factor for stroke, with arterial stiffness as a major indepen-
dent determinant of increasing systolic and pulse pressure
and a tissue biomarker of cardiovascular risk factors. It is
becoming increasingly clear that VSMC plasticity signif-
icantly contributes to arterial stiffening in ageing (Lacolley
et al. 2012; Sehgel et al. 2015). The process of phenotypic
switching requires a specific pattern of transcriptional
factors, in particular the SRF and myocardin, and
microRNA expression whose mechanisms are now begin-
ning to emerge. Using the conditional SMC-inactivation
of SRF genemousemodel, SRF controls pressure-induced
myogenic tone and vasoconstriction in mesenteric arteries
via VSMC phenotypic modulation linked to changes in
contractile protein gene expression (Galmiche et al. 2013).
SRF-related decreases in vasomotor tone and cell-matrix
attachment increase arterial elasticity in large arteries. By
contrast, in mice with inducible SRF overexpression, the
in vitro contractile response was significantly increased in
all arteries. Using the knock-out (KO) mouse model of
intermediate filament genes such as desmin and vimentin,
they have shown that a lower distensibility and an increase
of arterial wall viscosity in desmin KO mice (Lacolley
et al. 2001), and vimentin ablation results in decreased
arterial pressure and increased carotid wall stiffness
(Langlois et al. 2017). They observed that several endo-
thelial markers are up-regulated and content of several
components of basement membrane such as laminin, fi-
bronectin, and perlecan is increased in vimentin KOmice,
suggesting a role of endothelial cells in vascular stiffness.
Congestive heart failure
As stated above, CVD also encompasses congestive heart
failure, a morbid disorder whose prevalence strongly in-
creases with the ageing of the world population and the
spread ofWestern dietary pattern. Despite continuous prog-
ress in the therapy of heart failure, which ismainly based on
the use of β-blockers, neurohormonal antagonists, and
diuretics, morbidity and mortality remain high for this
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disease and the economical and societal costs keep rising.
One major issue that is poorly addressed in current heart
failure therapy is the severely depressed bioenergetics func-
tions in the failing heart. Indeed, the failing heart is charac-
terized by deficient mitochondrial functions leading to a
decrease in high-energy phosphate metabolites levels (ATP,
phosphocreatine) and an increase in oxidative stress. Nico-
tinamide adenine dinucleotide (NAD+) is a major hydride-
transfer coenzyme in the process of glucose and fatty acids
oxidation and a major electron donor to the mitochondrial
electron transport chain allowing the synthesis of ATP.
NAD(H) is the sole precursor of NADP(H) which has a
dual role, either acting as the final donor of electrons in
oxygen radical detoxification systems (glutathione,
thioredoxin, etc.) or participating in the generation of su-
peroxide by NADPH oxidases in oxidative burst reactions.
Myocardial NAD+ level decreases in the failing heart of
many different mouse models of heart failure (Mericskay
2016). This decrease parallels the down-regulation of the
major NAD+ salvage pathway mediated by the NAMPT
enzyme in most forms of heart failure (Hsu et al. 2014).
Supplementation of food with NAD precursors can mark-
edly improve cardiac functions while preserving cardiac
energy metabolism and allowing the cardiac cells to cope
with pathological changes to the redox state. These findings
(Pillai et al. 2005; Yamamoto et al. 2014; Lee et al. 2016b)
suggest that maintaining NAD levels in the heart constitute
a new therapeutic avenue for the treatment of heart failure, a
syndrome strongly associated with ageing.
To address the issue of heart tissue injury, a new ap-
proach based on cardiac tissue engineering for heart failure
treatment has been developed. The principle of tissue
engineering mainly relies upon the promotion of cells
growth on a bio-inspired scaffold that mimics both phys-
ical and chemical properties of cardiac tissues (Kitsara
et al. 2016). To develop a new generation of cell therapy
products made of cellularized biomaterials, robust differ-
entiation protocols were developed to generate contractile
human cardiomyocytes derived from pluripotent stem cells
(Joanne et al. 2016). Different biomaterials composed of
nanofibers from extracellular matrix components were
developed (i.e., collagen, hyaluronic acid) or natural poly-
mers (i.e., fibrin, chitosan) mimicking the alveolar and
fibrous structure of the myocardium (Joanne et al. 2016;
Bellamy et al. 2015; Fiamingo et al. 2016). Moreover,
these biocompatible and biodegradable biomaterials could
be seeded with human cardiomyocytes, enabling the de-
velopment of functional cardiac-like tissue. Finally, en-
graftments of these cellularized biomaterials on the surface
of the heart demonstrate integration and functionality of
engineered tissues in animals (Joanne et al. 2016). In
conclusion, combining cardiac cells with the biomaterials
to control both biological and physical-chemical environ-
ments of the cells allows the development of new cell
therapy products for cardiovascular diseases.
Based on previous reports of a decreased ability to
activate the Nrf2 pathway in animal studies (Zhang
et al. 2012), it was hypothesized that the ability to activate
Nrf2 would decline in primary human cells with age.
Primary human bronchial epithelial (HBE) cells were
obtained from six different male, non-smoking subjects
(three from age 28–29 and three from ages 67–69). Three
comparisons were made by randomly pairing one young
with one old into groups. Cells of low passage were
treated with or without 2 μM sulforaphane for 12 h, and
the mRNAs of Nrf2-regulated antioxidant (phase II)
genesweremeasured. Unstimulated expression ofGCLC,
GCLM, HO1, and NQO1 genes was the same in the
young and old HBE. In contrast, sulforaphane-induced
phase II gene expression of the young HBE cells was
significantly greater than that in the older cells supporting
our hypothesis. Western blot analysis showed an increase
in Nrf2 accumulation within 1 h in cell nucleus after
stimulation with sulforaphane in both young and old cells,
suggesting that the difference in response occurs in the
nucleus. Bach-1 and c-Myc which are Nrf2 suppressors
were subsequently quantified at baseline and after stimu-
lation. The results mimic what has been observed in
several previously reported studies of animal organs.
Myocardial ischemia and reperfusion injury
The management of myocardial infarction has evolved
dramatically over the last 30 years. In the 1980s, reper-
fusion therapies were developed, first with thrombo-
lytics, and now with primary percutaneous coronary
interventions. It is well accepted that acute reperfusion
with angioplasty, thrombectomy, and stenting is the
current state-of-the-art treatments. Early reperfusion
therapy with percutaneous coronary interventions
(stents and/or balloon angioplasty) and/or thrombolytic
therapy has reduced the size of myocardial infarctions
and improved survival. However, despite falling door-
to-balloon times, mortality rates have plateaued. Ac-
cording to the American Heart Association, about 15%
of patients who experience a myocardial infarction in
any given year will die of it. While 30-day mortality
GeroScience (2017) 39:499–550508
rates still were reported to be 7.8 to 11.4% in some
analyses (Mozaffarian et al. 2015). Nearly a quarter of
older patients suffering a myocardial infarction will
suffer congestive heart failure after 1 year. Therefore
there is an unmet need to further reduce structural and
functional damage to the heart following a myocardial
infarction.
One approach is to further reduce myocardial infarc-
tion size. It is well recognized that the size of the
myocardial infarction is a major determinant of outcome
(Boden et al. 2013; Turer et al. 2005). The desired goal
is to decrease the myocardial infarction size above and
beyond reperfusion, by reducing reperfusion injury. In
this review, we will describe the four basic types of
reperfusion injury, potential mechanisms of reperfusion
injury, attempts to reduce reperfusion injury by scav-
enging or inhibiting the formation of ROS, and new
targets related to reperfusion injury.
In the early seconds to minutes of reperfusion, fol-
lowing a coronary artery occlusion, there is a burst of
reactive oxygen species (Zweier et al. 1987). These
reactive oxygen species include O2
·– and H2O2 that
may contribute to membrane damage, increase cell
membrane permeability, disrupt ion channels, and allow
for calcium overload to the cell.
There are four basic types of reperfusion injury:
reperfusion arrhythmias, stunned myocardium, micro-
vascular obstruction (no-reflow phenomenon), and le-
thal myocardial cell injury (which means that cells that
are viable at the end of the ischemic period die because
of reperfusion). Reperfusion arrhythmias include ven-
tricular arrhythmias such as ventricular premature beats,
runs of ventricular tachycardia, and ventricular fibrilla-
tion that may occur very early after reperfusion. These
arrhythmias are rarely a major clinical problem and are
treated pharmacologically if needed and usually subside
over time (Kloner et al. 2011).
Stunned myocardium
Stunned myocardium refers to previously ischemic via-
ble myocardium that has been salvaged by reperfusion,
in which there is prolonged, but transient post-ischemic
contractile dysfunction (Braunwald and Kloner 1982).
Early experimental studies showed that a brief 15-min
coronary artery occlusion followed by reperfusion did
not kill myocardial cells; rather these cells showed func-
tional abnormalities and subtle ultrastructural abnormal-
ities that resolved in a few days (Heyndrickx et al. 1975;
Kloner et al. 1983). During the coronary artery occlu-
sion, a regional wall motion abnormality was demon-
strated within the zone of ischemia; however, following
reperfusion and despite the fact that the reperfused myo-
cardium was viable, persistent ventricular wall motion
abnormalities persisted for several days (Heyndrickx
et al. 1975; Kloner et al. 1983). Hence, the myocardium
behaved as if it were stunned. Using ultrasonic crystals
implanted into the wall of the left ventricle to track
percent segment shortening, Przyklenk et al.
(Przyklenk and Kloner 1986) showed that superoxide
dismutase and catalase, given prior to, during occlusion
and during reperfusion, improved the recovery of the
segment shortening within the stunned segment. This
finding and those of the Bolli group (Bolli 1988)
showed that the mechanism of stunned myocardium
involved reactive oxygen species and that a potential
therapy for stunned myocardium was oxygen radical
scavengers. Another theory regarding stunning was that
calcium overload into the cells, due to increased perme-
ability and damage to membranes caused by reactive
oxygen species, then desensitized the contractile appa-
ratus to calcium, preventing normal myofilament func-
tion. We observed that in similar experimental models
that the calcium channel blocker, nifedipine, also im-
proved the function of stunned myocardium (Przyklenk
et al. 1989).
Stunned myocardium has been described in patients
and includes the following: gradual return of regional
function following thrombolytic therapy for acute myo-
cardial infarction; prolonged left ventricular regional
wall motion abnormalities in patients with unstable an-
gina, persistent left ventricular regional wall motion
abnormalities following exercise-induced ischemia,
and prolonged but reversible left ventricular dysfunction
following cardiac surgery (Patel et al. 1988). Stunned
myocardium does respond to inotropic stimulation
(Arnold et al. 1985). In the setting of post myocardial
infarction, stunning or post cardiac surgery stunning
where heart failure is an issue, inotropes are often used
to hold the patient over until the stunning recovers.
Because stunning does eventually resolve, by definition,
it can usually be managed in the clinical setting using
general measures such as inotropes.
No-reflow phenomenon
The no-reflow phenomenon is the inability to reperfuse
regions of the myocardium after re-establishing patency
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of an occluded epicardial coronary artery. The usual
cause is microvascular obstruction. Experimental stud-
ies showed that following release of a 90-min or longer
coronary artery occlusion in the canine model of myo-
cardial infarction that the markers of flow do not perfuse
portions of the subendo-and mid-myocardium, despite
the fact that the epicardial infarct artery is patent (Kloner
et al. 1974). These zones of no-reflow are characterized
by anatomic evidence of microvascular obstruction. Ul-
trastructural analysis within the zone of no-reflow re-
vealed localized swelling and protrusions of the endo-
thelium that appear to block the lumen. It was also
observed the no-reflow phenomenon in other species
including rabbit and rat with as little as 30 min of
coronary artery occlusion followed by reperfusion.
There is evidence that no-reflow is a true form of reper-
fusion injury. It was observed that size of the no-reflow
zone expands over the first few hours after reperfusion
of an epicardial coronary artery, suggesting worsening
microvascular damage during the phase of reperfusion
(Reffelmann and Kloner 2002). In other experimental
studies, we observed that no-reflow correlates with
worsened left ventricular remodeling during the chronic
phase of infarction. Ventricles with no-reflow are likely
to demonstrate more thinning and stretching of the
infarct wall and left ventricular dilatation (Reffelmann
et al. 2003). The most likely explanation for this is that
no-reflow inhibits the efflux of cellular debris from the
necrotic core and limits entrance of those humoral fac-
tors and cells that are important to the healing phase
such as macrophages and fibroblasts. Studies by
Przyklenk and Kloner showed that oxygen radicals
may play a role in the microvascular damage associated
with no-reflow. Upon administration of superoxide dis-
mutase and catalase, given just prior to reperfusion after
a 2-h proximal coronary artery occlusion, improved
regional myocardial blood flow measured with radioac-
tive microspheres in the endo-, mid-, and epicardial
layers of the myocardium. In addition, superoxide dis-
mutase and catalase improved the ultrastructural appear-
ance of the microvessels (Przyklenk and Kloner 1989).
Of note, these benefits of the oxygen free radical scav-
engers were independent of any effect on myocardial
infarct size, since these drugs did not reduce infarct size
in our models. Other experimental therapies that have
reduced the no-reflow phenomenon in our myocardial
infarct models include therapeutic hypothermia, when
administered either early, during the phase of ischemia,
in which it also reduces myocardial infarct size (Hale
et al. 2003); or when administered late, after reperfusion
has already been established, in which case it reduces
the no-reflow zone but has no effect on myocardial
infarct size (Hale et al. 2013). Finally we recently ob-
served that the mitochondrial targeted peptide,
elamipretide, which is known to reduce the generation
of reactive oxygen species from themitochondria during
stress, reduced the size of the no-reflow zone for any
given risk zone in a rabbit model of coronary artery
occlusion (Kloner et al. 2012).
No-reflow has been documented in patients follow-
ing reperfusion of the epicardial infarct related arteries.
Perfusion defects within the myocardium have been
observed by contrast enhanced magnetic resonance
imaging, echocardiographic contrast injections, and nu-
clear studies (Kloner 2011). In the catheterization labo-
ratory, low TIMI grades, long TIMI frame counts, and
reduced myocardial blush grades and slow resolution of
ST elevation on the ECG are other findings consistent
with no-reflow (Rezkalla et al. 2010). Patients who
demonstrate no-reflow after myocardial infarction also
demonstrate more adverse left ventricular remodeling
including a more dilated ventricle (Kloner 2011), which
parallels the findings described in the experimental lit-
erature. Patients who demonstrate no-reflow following a
myocardial infarction have worse survival rates than
patients without no-reflow and this observation is inde-
pendent of infarct size. No-reflow in humans may differ
somewhat from that described in the experimental
models as it also can involve micro-emboli of athero-
sclerotic and embolic debris released downstream into
the microvasculature following coronary balloon infla-
tion and/or stent deployment. While there is no stan-
dardized therapy for treating no-reflow in the catheteri-
zation laboratory, some of the strategies that have been
employed include adenosine, verapamil, nitroprusside,
systemic anticoagulation and platelet 2B-3A receptor
blockers, aspiration thrombectomy, and distal protection
filters (Kloner 2011).
Lethal myocardial cell injury
Lethal cell injury is the most important, but probably the
most controversial, of the forms of reperfusion injury.
Here, cells that are reversibly injured at the end of a
period of ischemia become irreversibly injured by the
act of reperfusion. Presumably reactive oxygen species
generation, coupled with calcium overload lead to addi-
tional cellular damage at the time of reperfusion. If a
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drug or other therapy is administered at the time of
reperfusion and the size of the myocardial infarction is
reduced compared to reperfusion alone, then this finding
would support the concept that reperfusion injury exists
and that the adjunctive therapy was working by limiting
reperfusion injury. While some studies suggest that
drugs given at reperfusion can limit the size of a myo-
cardial infarction (Yellon and Hausenloy 2007), other
studies show contrary results. These studies have dem-
onstrated that for an adjunctive therapy to limit myocar-
dial infarct size, the drug or therapy had to be on-board
during a substantial phase of ischemia or given before
ischemia. Thus therapies such as hypothermia (Hale
et al. 2003, 2013), remote ischemic conditioning
(Przyklenk et al. 1993), calcium channel blockers (Lo
et al. 1985), and beta blockers (Rasmussen et al. 1977)
which reduced infarct size in some of these models
needed to be present prior to or during the ischemic
insult. Given only after reperfusion, they did not work.
Hence, postconditioning did not reduce myocardial in-
farction size in these models (Dow and Kloner 2007).
Similarly, superoxide dismutase and catalase, given at
reperfusion, failed to reduce myocardial infarct size, but
did reduce microvascular obstruction (Przyklenk and
Kloner 1989). In general, clinical trials reducing infarct
size by giving agents at reperfusion have been disap-
pointing (Gerczuk and Kloner 2012). Recent clinical
trials involving postconditioning and mitochondrial per-
meability pore blocking agents (cyclosporine) have
been negative (Kloner et al. 2017). An older study,
utilizing superoxide dismutase was negative (Flaherty
et al. 1994). Some studies showing certain adjunctive
agents when given during ischemia, but prior to reper-
fusion, reduced infarct size in clinical trials including
adenosine, remote ischemic conditioning, successful
hypothermia in patients with anterior infarcts,
hyperoxemia, beta blockade, and others.
In summary, there are several forms of reperfusion
injury. Stunnedmyocardium and the no-reflow phenom-
enon are well documented in both preclinical experi-
mental models and in patients. Therapies are available
for both, but there is a clinical need to better develop
systematic therapy for no-reflow. Such therapy has the
potential to enhance healing after a myocardial infarc-
tion, reduce adverse left ventricular remodeling, reduce
heart failure, and improve survival. The concept of
lethal myocardial cell injury, due to reperfusion, remains
somewhat controversial in our opinion. However, since
there is time to administer agents to patients with
infarcts prior to reperfusion therapy in the ambulance
or emergency room, there is still the potential to reduce
myocardial infarct size above and beyond reperfusion.
Lung injury, oxygen, and acute respiratory distress
syndrome
Oxygen and its potential for toxicity has compounded
the management of acute lung injury and the acute
respiratory distress syndrome (ARDS). Though there
are multiple causes for ARDS, the ultimate insult is an
injury to the endothelial barrier to the vasculature and
leakage of protein-rich fluid into the alveoli. This results
in severe hypoxemia and acute respiratory failure. Clin-
ical studies over the past four decades have shown slow
progress in the management of ARDS.
In the 1970s, high fraction of inspired oxygen (FIO2),
volume ventilation, and positive end expiratory pressure
allowed for some improvement in maintaining
normoxemia (Petty and Ashbaugh 1971). The addition
of larger tidal volumes (10–15 cm3/kg), in the 1980s and
early 1990s, became the standard of care in the ICU
management. However, this approach was accompanied
by severe life-threatening complications of barotrauma
while attempting to find a ^safe^ FIO2 (Pierson 2013).
Failure to lower FIO2 usually resulted in worsening lung
injury and increased mortality. At the turn of the twenty-
first century, the ARDS network confirmed the value of
lung protective ventilation with lower tidal volumes (5–
6 cm3/kg) and airway pressures than in prior decades,
resulting in improved survival (Brower et al. 2000).
The avoidance of oxygen toxicity led to reliance
on higher levels of positive end-expiratory pressure
(PEEP). The reduction in tidal volume continues to
persist and remains the oxygen paradox with some
boundaries for clinicians but no simple solutions.
Though numerous medications including steroids,
non-steroidal anti-inflammatory agents, surfactants,
and nitrous oxide have been tested. There is no
approved medication for ARDS. The next area of
study is moving from barotrauma to biotrauma. The
one new area of drug research involves stabilizing
the endothelial injury with interferon-β (IFN-β)
(Traumakine) (Bellingan et al. 2014). The intrave-
nous infusion stabilizes the injury by replacing the
loss of CD 73 (5′Nucleatidase). Currently it is in
stage 3 clinical trials in Europe and Japan and
awaiting final approval.
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Liver and the French Paradox
The liver plays a crucial role in overall human health and
is necessary for proper immune function and lipid and
carbohydrate metabolism (Rouiller 2013). Loss in hepat-
ic homeostasis can result in debilitating conditions, one
of the most prevalent being nonalcoholic fatty liver
disease (NAFLD). NAFLD encompasses a broad spec-
trum of pathological conditions, ranging from steatosis at
the early stages, to nonalcoholic steatohepatitis (NASH)
and cirrhosis as the disease progresses. The early stages
of the disease are characterized by the accumulation of
triglycerides (TAG) in over 5% of hepatic cells, resulting
in not only ectopic fat accumulation, but the negative
repercussion of low-grade chronic inflammation
resulting in tissue normally not accustomed to lipid
accumulation (Fabbrini et al. 2010). Eventually, if not
corrected, NAFLD can lead to liver failure (Musso et al.
2011) and/or hepatocellular carcinoma (Marrero et al.
2002).
Currently, in the USA, over 30% of adults will de-
velop NAFLD, with this percentage predicted to rise
with age (Browning et al. 2004). The increase in disease
prevalence is largely attributed to excess caloric con-
sumption, largely resulting from calorie-dense western-
ized diets. In turn, excess caloric intake not only pro-
motes NAFLD, but loss in blood glucose regulation.
Hence, it is of little surprise that the rise in NAFLD
coincides with the increasing development of the meta-
bolic syndrome, which is a generalized term for meta-
bolic abnormalities, including increased abdominal fat,
insulin resistance, and high blood pressure and blood
triglycerides (Alberti et al. 2005). NAFLD stems from
hepatic TAG generation exceeding the rate of hepatic
TAG catabolism (Birkenfeld and Shulman 2014). In-
deed, as early as 3 days following consumption of high
fat-diets can induce hepatic insulin resistance in mice
and rats (Samuel et al. 2004). Thus, NAFLD has been
aptly coined as the hepatic manifestation of the meta-
bolic syndrome (Lebovics and Rubin 2011).
Unless corrected, metabolic complications can in-
crease the risk of developing type II diabetes mellitus
(T2DM), predominantly characterized by loss in insulin
sensitivity (insulin resistance), and is a disease strongly
associated with NAFLD. Moreover, the prevalence of
individuals with T2DM and NAFLD is almost double
the amount found in age-matched healthy controls,
ranging from 50 to 75% (Targher et al. 2007). Conse-
quently, these individuals are at a greater risk for
developing more advanced forms of NAFLD, and ulti-
mately, increased risk of mortality (Ong et al. 2008).
Paradoxically, the French diet, which is primarily
known for its rich diet (i.e., foods high in saturated fats),
which are known contributors of chronic conditions,
including NAFLD and coronary artery disease, yet strik-
ingly shows a relatively low prevalence in the French
population (Gambini et al. 2015). This has been attrib-
uted to the relatively high consumption of red wine,
characterized for its highly beneficial components, in-
cluding polyphenols, which is the staple drink in the
French diet. One of the most well-characterized compo-
nents of red wine is resveratrol and has been linked to
numerous beneficial health improvements (Yang and
Lim 2014). Indeed, studies in mice fed a high fat diet
supplemented with red wine showed improved glucose
tolerance, insulin sensitivity, and decreased hepatic
steatosis. Moreover, when the same animals were fed
the Bwaste^ product of the wine extraction, pomace,
caused the greatest improvements in these markers
(Rosenzweig et al. 2017). However, it is important to
note that excess alcohol consumption can have detri-
mental effects, and individuals should practice modera-
tion in the extent and type of alcohol that they consume.
Cancer and carcinogenesis
Among the main non-communicable diseases, cancer
represents the leading cause of death worldwide, with
approximately 8.2 million deaths and 14 million new
cases in 2012 (Stewart and Wild 2014). Western popu-
lations are the most affected, especially in France and in
the USA, with an age-standardized rate for all cancers
higher than 300 cancers per 100,000 people in 2012
(Ferlay et al. 2015). When diagnosed, several therapies
such as chemotherapy, radiation therapy, or surgery (or
multiple forms of combination therapies) are used to
treat cancer, depending on type, localization, and grade.
In addition, patients’ diet and physical activity levels are
known to modulate the efficiency of these anticancer
treatments, but the molecular mechanisms remain un-
known (Friedenreich et al. 2010; Davies et al. 2011).
Oxidative stress is a key factor in both carcinogenesis
and response to anticancer therapies, increasing the
interest in reactive oxygen species-targeted therapies
(Gorrini et al. 2013; Gentric et al. 2017; Batista et al.
2013; Costa et al. 2014). Among them, physical activity
and antioxidant supplementation have progressively
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become recognized as key actors in preventing cancer
development (Gueritat et al. 2014; Rebillard et al. 2013).
We address new insights on the controversial role of
reactive oxygen species in carcinogenesis and in re-
sponses to chemotherapy and/or adjuvant therapies.
Moreover, we elaborate on the benefits of individualiz-
ing the treatment according to the tumor redox status.
The double face of reactive oxygen species in cancer
Altered redox balance is an important hallmark of cancer.
In 2009, Luo et al. added on the list of common cancer
characteristics a new set of hallmarks called BStress phe-
notype of cancer .^ Among these are DNA damage, mi-
totic stress, metabolic stress, and oxidative stress, which
are all sensitive to reactive oxygen species-mediated sig-
naling (Luo et al. 2009). The levels of oxidatively dam-
aged DNA (i.e., 8-oxo-7,8-dihydroguanine (8-oxoGua)),
lipid peroxidation adducts [i.e., 4-hydroxy-2-nonenal (4-
HNE) and malondialdehyde (MDA)] and/or protein car-
bonyls increase in blood samples, urine excretion, and
tumor tissue of patients with breast, colorectal, lung,
prostate, esophageal, and thyroid cancer (Sheridan et al.
2009; Crohns et al. 2009; Lagadu et al. 2010; Young et al.
2010; Kosova et al. 2014). Some studies also reported
that the levels of oxidatively induced damage correlates
with poorer survival or even with more advanced stages
of the disease (Crohns et al. 2009; Dziaman et al. 2014).
Accordingly, cancerous tissues have been found to pro-
duce elevated levels of H2O2, compared to adjacent nor-
mal tissues (Szatrowski and Nathan 1991). In the same
way, polymorphisms in antioxidant genes are linked to
increased cancer incidence (Freriksen et al. 2014). Final-
ly, resistance to reactive oxygen species-producing che-
motherapeutic agents is directly proportional to the cel-
lular antioxidant capacity of the patients (Ramanathan
et al. 2005).
Reactive oxygen and nitrogen species, mainly pro-
duced by xanthine oxidase (XO), NADPH oxidases
(NOX), nitric oxide synthase (NOS), and inducible ni-
tric oxide synthase (iNOS) and mitochondria in cancer
cells (Huang et al. 2015; Roy et al. 2015; Panieri and
Santoro 2016), play a dual role in cancer, depending on
the levels generated within the cell or in the microenvi-
ronment. Reactive oxygen species, particularly the hy-
droxyl radical (·OH) induce DNA mutations that might
lead to tumor initiation and promotion by targeting
tumor suppressor and pro-oncogenic genes
(Higinbotham et al. 1992). Together, oxidatively
generated DNA damage, coupled with a defective repair
system, are widely accepted as important mutagenic
factors involved in carcinogenesis (Loft and Poulsen
1996). The sustained presence of reactive oxygen species
is associated with the development of metabolic pertur-
bations that provide cancer cells with amino acids, lipids,
and nucleotides to further boost their uncontrolled prolif-
eration (Sainz et al. 2012). It is important to note, the
amounts of intracellular reactive oxygen species are well
controlled in cancer cells, depending on the stage: low-to-
moderate reactive oxygen species levels are produced
during malignancy transformation (Bostwick et al.
2000; Cullen et al. 2003; Sander et al. 2003). Yet, upon
cancer progression, reactive oxygen species production is
limited, protecting malignant cells from cell death
(Sander et al. 2003; Durak et al. 1993; Portakal et al.
2000; Janssen et al. 2000). This redox harmony between
antioxidant and pro-oxidant species is the main secret
behind cancer progression. The type of tumor, the context
of tumor’s microenvironment, and the nature of stimuli
will determine if reactive oxygen species will shift the
balance toward a pro-survival or pro-death response
(Gentric et al. 2017; Costa et al. 2014).
Chronic oxidative stress improves responses
to anticancer treatment: underlying mechanisms
identified in aggressive breast cancer and ovarian
carcinomas
Women patients affected by triple-negative breast can-
cers and ovarian high-grade serous carcinomas, the most
aggressive form of breast and ovarian cancers, are gen-
erally treated with platinum- or taxane-based chemother-
apy (e.g., cisplatin, paclitaxel), two powerful generators
of both reactive oxygen species and consequent DNA
damage (Alexandre et al. 2007). Interestingly, while
chronic oxidative stress increases tumor growth and
spread, recent studies have demonstrated that high basal
reactive oxygen species levels in breast and ovarian
adenocarcinoma cells also improve response to reactive
oxygen species-producing chemotherapy (Gruosso et al.
2016; Mateescu et al. 2011). These beneficial effects are
mediated by increased cancer cell apoptosis
(Ramanathan et al. 2005; Mateescu et al. 2011; Batista
et al. 2016), modulation of autophagy (Lefort et al.
2014), regulation of MEK pathway (Gruosso et al.
2015), and DNA damage response (Gruosso et al. 2016).
In the last years, Mechta-Grigoriou’s research group
identified the microRNA miR-200 family as a new
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molecular player linking chronic oxidative stress and
chemosensitivity (Mateescu et al. 2011; Batista et al.
2016). Many adaptive mechanisms that modulate gene
expression are activated in response to oxidative stress,
including the p38α mitogen-activated protein kinase
(MAPK) family, recognized to suppress tumorigenesis
by blocking proliferation or promoting apoptosis (Hui
et al. 2007; Wagner and Nebreda 2009). Interestingly,
Mateescu and colleagues showed that the acute oxida-
tive stress increases miR-200 family expression (miR-
141 and miR-200a) in non-transformed cells, thus
inhibiting p38α activity and promoting malignancy
(Mateescu et al. 2011). However, while overexpression
of miR-200a expression decreases p38α/MAPK14 pro-
tein in ovarian adenocarcinomas and promotes tumori-
genesis, it enhances tumor cell death and slows tumor
growth under treatment with paclitaxel (Taxane family
group) (Mateescu et al. 2011). These observations dem-
onstrate the tight relationship between miR-200 family
members, oxidative stress, and cell apoptosis that has
been validated by many other studies (Batista et al.
2016; Magenta et al. 2011; Xiao et al. 2015). It has been
recently confirmed that miR-200c and miR-141 sensi-
tize ovarian cancer cells to paclitaxel, but confer resis-
tance to carboplatin (Brozovic et al. 2015). Interestingly,
paclitaxel is a reactive oxygen species-producing che-
motherapeutic agent and its efficacy has been directly
linked to antioxidant defenses detected in patient blood
(Ramanathan et al. 2005). Taken as a whole, these works
emphasize the crosstalk between intracellular reactive
oxygen species levels in tumors and levels of antioxi-
dant defenses in response to reactive oxygen species-
producing therapies, such as paclitaxel.
More recently, Mechta-Grigoriou’s research group
identified the histone variant H2AX, a key component
in DNA repair, as being degraded by chemotherapy in
Triple-Negative (TN) breast cancer patients (Gruosso
et al. 2016). Importantly, H2AX decrease is a marker
of chemotherapy efficiency. This study newly demon-
strates that chronic oxidative stress, due to JunD−/Nrf2-
deficiency, promotes degradation of H2AX by the E3
ubiquitin ligase RNF168. Gruosso and colleagues re-
ported that cycles of chemotherapy (Adryamicin/Cyclo-
phosphamide and Taxanes) given to TN breast cancer
patients drives an Nrf2-antioxidant response. The extent
of this antioxidant response in patients is linked to
H2AX maintenance and resistance to chemotherapy. In
tumor cells with low Nrf2-antioxidant response after
treatment, the levels of reactive oxygen species remain
high, H2AX is efficiently degraded, further reducing
repair of DNA damage induced by the drug, tumor cell
apoptosis is subsequently increased, and patient survival
improved (Gruosso et al. 2016).
Physical exercise and antioxidant supplementation
to target reactive oxygen species in tumor: the need
to individualize according to cancer grade
During the last decade, studies investigating the impact of
physical activity (PA) on cancer have increased exponen-
tially giving birth to a new field named Bexercise-
oncology.^ Mainly motivated by the evidence that PA
could decrease cancer incidence, with a linear dose-
response relationship in breast and colon cancer
(Ballard-Barbash et al. 2012). Emerging data from breast,
colon, and prostate cancer indicate that physically active
patients exhibited less recurrence and mortality, highlight-
ing a possible role for PA in the reduction of tumor growth
(Meyerhardt et al. 2006; Friedenreich et al. 2016).
The ability of exercise to mimic an antioxidant re-
sponse has been suggested as a mechanism to counteract
the role of reactive oxygen species in tumor growth (de
Sousa et al. 2016). In a murine model of low-grade
prostate cancer, Gueritat and colleagues demonstrated
that regular physical training reduced prostate tumor
growth (Gueritat et al. 2014). Although intratumoral
protein carbonyls and lipid peroxidation breakdown
products (i.e., 4-HNE) were unaffected, the levels of
oxidatively generated DNA damage (i.e., 8-oxoGua)
were significantly reduced by physical activity. These
events were probably due to a decrease in intracellular
reactive oxygen species in tumor, as the activation of the
redox-sensitive kinase ERK1/2 was also attenuated. Ac-
cordingly, since ERK1/2 plays an important role in
promoting tumor growth, its inhibition by exercise was
positively reverberated on the rate of tumor cell prolif-
eration (Gueritat et al. 2014).
Based on the idea that exercise training acts as an
antioxidant in tumors (Gueritat et al. 2014), exogenous
antioxidants may induce similar effects and, therefore,
could substitute physical exercise in advanced stages of
cancer, when its use is not tolerated by the patient.
Nutritional support, including antioxidant supplementa-
tion, is generally used to reduce the adverse side effects
of anticancer therapies, like muscle wasting, mucositis,
and fibrosis (Fig. 3) (Borek 2004).
However, recent preclinical and clinical findings
showed antioxidant treatment for aggressive cancers
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was detrimental. The Swedish team of Martin Bergo
demonstrated that vitamin E or N-acetylcysteine
(NAC) reduced survival and accelerated lung cancer
progression in mice (Sayin et al. 2014) and enhanced
malignant melanoma metastasis to lymph nodes and
lungs in mice with Braf and Pten mutations (Le Gal
et al. 2015). Similarly, Piskounova et al. showed NAC
increased the number of melanoma cells in blood and
metastatic burden in NSG mice bearing aggressive mel-
anoma xenografts from patients (Piskounova et al.
2015). Consistent with these findings, Assi and col-
leagues found that supplementation with an antioxidant
mixture containing vitamins, oligoelements, and poly-
phenols reduced survival and enhanced C26 colon tu-
mor growth in cachectic mice (Assi et al. 2016).
On the contrary, studies using a low grade cancer
model, antioxidant supplementation prevents tumori-
genesis. Indeed, Gueritat and colleagues observed that
natural antioxidants reduced the volume and delayed the
growth of low-grade AT-1 prostate adenocarcinoma in
rats (Gueritat et al. 2014). Similar findings occurred in
mice bearing differentiated breast MCF-7 tumor (Liao
et al. 1995) or Dalton’s lymphoma ascites (Sharma and
Vinayak 2013). Clinically, histological studies found a
decrease in the expression/activity of antioxidant
enzymes in precancerous tissues (Bostwick et al. 2000;
Cullen et al. 2003; Sander et al. 2003). In contrast,
advanced grades of cancer showed increased
expression/activity of antioxidant enzymes in tumor
tissues (Sander et al. 2003; Durak et al. 1993; Portakal
et al. 2000; Strzelczyk et al. 2012). The combination of
preclinical and clinical data let us suppose that interven-
tions with antioxidants could be plausible at early stages
of cancer, but harmful in advanced stages.
Oxidatively generated DNA damage: potential
biomarkers for cancer progression monitoring
which need to be correctly assessed
The dose-dependent effects of physical exercise or an-
tioxidant supplementation supports the idea that moni-
toring tumor redox status could be a promising thera-
peutic strategy in the care management of cancer pa-
tients. Among the different biomarkers that could be
used to assess redox status of tumor cells, oxo-7,8-
dihydro-2′-deoxyguanosine (8-oxodG) has gainedmuch
attention. However, its role as a reliable marker of
cancer progression is still under debate, as its levels in
blood, urine, or tumor tissues to predict survival and
efficacy of anticancer treatment is still under debate
Fig. 3 Dual effects of antioxidant supplementation in cancer
initiation and development. A combination of preclinical and
clinical data provide support for the concept that intervention with
nutritional antioxidants might be beneficial at early stages of
cancer, but harmful in advanced stages. Early stages of cancer
are associated with a decrease in antioxidant response contributing
to increased reactive oxygen species (ROS) and consequent oxi-
dative damage with malignant transformation. In this situation,
supplementation with oral antioxidants might impede the pro-
cancerous oxidant actions. During the progression of cancer, ma-
lignant cells enhance their metabolic activity to meet their increas-
ing energetic needs, resulting in a higher generation of ROS. To
subsist in such condition, cancerous cells activate signaling path-
ways to increase the intracellular pool of antioxidant systems and
protect themselves against excessive oxidative damage. Conse-
quently, in late stages of cancer, supplementation with antioxidants
could actually strengthen tumor protection and help malignant
growths avoid cell death
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(Sheridan et al. 2009; Crohns et al. 2009; Roszkowski
et al. 2011; Roszkowski and Olinski 2012; Shen et al.
2007; Karihtala et al. 2011; Lee et al. 2010a).
The difficulties to establish links between cancer
progression and levels of oxidatively generated DNA
damage is largely explained by inaccurate quantification
of 8-oxodG. It is now well documented that several
assays, including gas chromatography-mass spectrome-
try (GC-MS) and [32P]-postlabeling methods, suffer
from major flaws during sample preparation (Cadet
et al. 2011, 2012), leading to overestimation of 8-
oxodG. In addition, immunoassays, which are still wide-
ly and improperly applied in clinical studies, are inac-
curate due to antibody cross-reactivity (Lee et al. 2010a;
Cadet et al. 2011). High performance liquid chromatog-
raphy coupled with electrospray ionization tandemmass
spectrometry (HPLC-ESI-MS/MS) in the multiple reac-
tion monitoring mode has become a relevant alternative
thus providing unambiguous damage characterization
and quantitative information (Lee et al. 2010a; Cadet
et al. 2011). However assessing low variations in 8-
oxodG levels by HPLC-ESI-MS/MS is still a challenge
(Badouard et al. 2008). An additional alternative is the
indirect detection of 8-oxodG or oxidized pyrimidine
bases, mediated by either the comet assay or the alkaline
elution technique, in association with DNA repair en-
zymes that convert basemodifications into strand breaks
(Klungland et al. 1999; Sauvaigo et al. 2002).
The measurement of 8-oxodG and 8-oxoGua, the
related nucleobase, in human fluids including urine,
plasma, and saliva offers a non-invasive method to
indirectly assess oxidatively generated damage in nucle-
ar DNA (Cooke et al. 2008). However, the biological
meaning of urinary 8-oxodG remains to be established
since it was recently reported that the release of the
oxidized nucleoside could not be accounted for by either
the nucleotide excision repair from DNA or MTH1-
mediated hydrolytic dephosphorylation of 8-oxo-7,8-
dihydro-2′-deoxyguanosine 5′-triphosphate in nucleo-
tide pools (Evans et al. 2016).
These studies show that tumor redox status affects
tumor development and impacts anticancer therapies.
Physical exercise and antioxidant supplementation are
proposed to optimize the effects of some specific agents,
while being deleterious for Taxane family drugs. Future
steps will require the identification of a patient’s tumor
redox status. To achieve this goal requires the identifi-
cation and validation of biological markers of oxidative
stress to make the right diagnosis. As such, oxidatively
DNA damage constitutes a promising biomarker, but
requires an improved standardized and clinically rele-
vant approach.
Neurological disorders and stroke
Stroke
There is a long-standing link between neurodegener-
ative disorders, stroke, and oxidative stress. In gener-
al, the brain is particularly sensitive to oxygen over-
load and free radical generation, as it requires higher
levels of oxygen and glucose than do other organs and
tissues. Additionally, the brain’s high amounts of un-
saturated fatty acids, with their easily oxidized double
bonds, makes it highly susceptible to free radical
attack (Butterfield et al. 2002). In strokes and the
onset of cerebral ischemia, a decrease in oxygen levels
removes controls over the free radicals generated by
electron transport and leads to decreased levels of
antioxidants, such as vitamins E and C, as they are
consumed in the attempt to quench the increase in free
radicals (Flamm et al. 1978). Even following the im-
mediate danger of a stroke, free radicals continue to
exert detrimental effects that lead to other complica-
tions such as brain edema, which can result from
disruption of the blood brain barrier leading to fluid
accumulation (Heo et al. 2005). There are some prom-
ising results suggesting that free radical scavengers
may be beneficial in remediating post-stroke symp-
toms in a clinical setting (Toyoda et al. 2004), making
antioxidant therapies a potentially promising avenue
for treatment following strokes. Another type of
stroke associated with oxidative damage is intracere-
bral hemorrhage or hemorrhagic stroke. In this type of
stroke, free radicals are produced in two ways, the first
is through the decomposition of blood that has rapidly
accumulated in the brain, which in turn releases iron
ions, heme, and thrombin that induce the production
of free radicals. Second, the inflammatory response by
cells such as microglia and neutrophils also generate
free radicals. Together both sources of free radicals are
leading causes of hemorrhagic brain tissue (Duan
et al. 2016). These examples illustrate that often the
events following a stroke are just as lethal with oxi-
datively generated damage playing a key role in the
toxicity, making antioxidant therapies a promising
treatment option.
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Alzheimer disease
Neurological disorders such as Alzheimer’s disease,
amyolotrophic lateral sclerosis (ALS), Multiple
Sclerosis (MS), and Parkinson’s disease all include
elements of redox imbalance (Uttara et al. 2009).
Whether free radicals and oxidative stress are in-
volved in both the initiation and the progression of
(each of) these diseases, however, is not so clear.
For example, Alzheimer disease is characterized by
the accumulation of amyloid-β peptides to form
amyloid plaques, which cause neuronal death
(Butterfield et al. 2002). Evidence indicates that
these aggregates then interact with redox metals to
initiate the production of free radicals further pro-
moting oxidative stress (Varadarajan et al. 2000).
The inability to maintain a homeostatic balance be-
tween production of amyloid-β peptides and their
degradation results in not only the elevation of ox-
idative stress but also the inhibition of proteasome-
driven protein degradation (Bonet-Costa et al.
2016), which further contributes to the cascading
effect of amyloid plaque formation. Exhibiting a
similar neuropathology to Alzheimer disease is
Down Syndrome (DS), a congenital birth defect that
is the result of three copies of chromosome 21.
Similar to Alzheimer disease, a redox imbalance
likely has some role in the adverse effects of DS.
One gene coded on chromosome 21, CuZn superox-
ide dismutase, has activity increased by 50% in DS.
This enzyme is responsible for catalyzing the
dismutation of superoxide to molecular oxygen and
hydrogen peroxide, and increased activity of this
enzyme may lead to greater production of hydrogen
peroxide (Brugge et al. 1992). Additional similarity
between DS and Alzheimer disease is found in the
formation of amyloid plaques. In DS, the gene for
amyloid A4 precursor is also located on chromo-
some 21 and is present at a rate 50% higher than
normal (Rumble et al. 1989), which is potentially
responsible for the amyloid plaque formed in DS.
RCAN1, a regulator of calcineurin, has also been
linked to both DS and Alzheimer disease as well as
another neurological disorders. Paradoxically,
RCAN1, specifically the isoform RCAN1-1L is neu-
roprotective against acute stress, but has detrimental
effects when chronically up-regulated. RCAN1-1L
is transiently elevated to defend against acute stress
including oxidative stress; however, long-term
elevation of RCAN1-1L is linked to DS and
Alzheimer disease (Ermak and Davies 2013). In
patients with Alzheimer disease, RCAN1-1L is
expressed twice as much relative to non-Alzheimer
disease controls suggesting that RCAN1-1L may
have a role in Alzheimer disease (Ermak et al.
2001; Harris et al. 2007).
For the individual, environment factors are major
determinants of health across the lifespan. Further stud-
ies of ApoE alleles on ageing processes need also to
consider environmental influences because the herita-
bility of human lifespan is 30% or less (Finch and Tanzi
1997; Dato et al. 2017). The Bbad^ ApoE4 allele is
associated with shorter lifespan and higher risk of
Alzheimer disease and cardiovascular disease. Its life-
shortening association was first reported in 1994 by
Schächter and colleagues at the Centre d’Etudes du
Polymorphisms Humain (Schächter et al. 1994).
However, ApoE4 is protective in some environ-
ments with high exposure to pathogenic infections.
In rural Ghana, ApoE4 had allele-dose benefits to
survival of adults and children (van Exel et al.
2017). Moreover, the Tsimane of low-land Bolivia
had better cognitive functions in ApoE4 carriers
who also had blood indicators of a high parasite
load (Trumble et al. 2017). Because ApoE4 is the
most ancient allele (Fullerton et al. 2000), its persis-
tence in human populations may represent its adap-
tive value under conditions of high pathogen expo-
sure (Finch and Stanford 2004; Martin and Finch
2016). The lower risk of age-related macular degen-
eration (AMD) in ApoE4 carriers (Section 12.3)
might be related to the increased UV exposure of
early humans in the African savannah, where there
is greater solar exposure than in the forest canopy of
our great ape ancestors. UV-induced retinal damage
is implicated in AMD (Kraljević Pavelić et al. 2015)
(Section 10.4).
In our highly polluted world, ApoE4 may increase
the risk of Alzheimer disease. Based on epidemiological
findings from the Womens’ Health Initiative Mental
Study (WHIMS), it was shown that older women resid-
ing in elevated particle density (PM2.5, above EPA
standards) had nearly double risk of dementia, with
further doubling of risk in E4/E4 carriers (Cacciottolo
et al. 2017). Correspondingly, EFAD mice carrying
transgenes for ApoE alleles and familial Alzheimer
disease had greater bran amyloid in the E4FAD carriers.
Given the low heritability of human lifespan, it is timely
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to expand environmental studies in discussions of hu-
man ageing mechanisms. The human environment is
being re-conceptualized in terms of the exposome, to
identify external and internal influences on individual
health and their synergies across the lifespan (of, N.A.
and E. Sciences, andMedicine 2017; Vineis et al. 2017).
The search for longevity associated gene variants might
also consider environmental factors that contribute to
life-shortening diseases.
Huntington disease
In contrast with high levels of RCAN1 expression in
Alzheimer disease, depressed levels of RCAN1-1L are a
hallmark of Huntington’s disease, a disease character-
ized by neuronal death caused by a mutant huntingtin
protein (Ermak et al. 2009). RCAN1-1L has been shown
to protect against toxic mutant huntingtin proteins
in vitro by inhibiting calcineurin, which in turn increases
phosphorylation of the mutant huntingtin protein. In
Huntington disease, there are elevated levels of bio-
markers for oxidative damage such as DNA damage
and oxidized proteins, which is believed to be the cause
of mitochondrial dysfunction and neuronal cell death.
The association between oxidative stress and Hunting-
ton disease is well documented, and multiple studies and
some clinical trials have shown antioxidant therapies to
be a promising candidate for slowing progression and
alleviating symptoms of Huntington disease (Gil-
Mohapel et al. 2014).
Multiple sclerosis
MS is an auto-immune neuronal disorder that causes
demyelination of the central nervous system (CNS).
Due to the abundance of reactive oxygen species, it is
arguably the disease source; however, the exact source
of MS is still unknown. Analysis of MS plaques re-
vealed elevated reactive oxygen species generation and
decreased antioxidant levels (Langemann et al. 1992).
Even though a cure to MS has yet to be developed,
dietary modifications have shown promising results in
delaying and easing symptoms ofMS. A low fat diet has
been shown to result in lower deterioration and death
rates (Swank and Dugan 1990). Similarly, a low fat diet
supplemented with the omega-3 fatty acids from fish oil
has also been shown to decrease the severity of MS
symptoms (Weinstock-Guttman et al. 2005). These
studies show that diets high in antioxidants and low in
oxidative strain have the potential to alleviate symptoms
of MS and delay its progression through the sequestra-
tion of free radicals and restoring redox balance.
Parkinson disease
Parkinson disease is characterized by a neuronal loss,
especially the nigral dopaminergic neurons and
intraneuronal inclusions called Lewy bodies and consti-
tuted mainly of α-synuclein. This results in the under-
representation of the neurotransmitter dopamine which
is at origin of the cardinal motor symptoms of the
disease: akinesia rigidity and tremor. The cause of neu-
ronal loss is not fully known but includes aggregation of
misfolded proteins (α-synuclein, tau), mitochondrial
dysfunction (especially a loss of complex 1 activity),
defective ubiquitine–proteasome proteolysis, and oxida-
tive stress.
Ultimately, dopamine neurons degenerate by an ap-
optotic process involving caspase 3 and 8 activation
(Hartmann et al. 2000; Hartmann et al. 2001). In addi-
tion to these so-called cell autonomous mechanisms,
non-ce l l au tonomous mechan i sms such as
neuroinflammatory processes or dysregulation of tro-
phic support also contribute to neuronal degeneration
and self-perpetuation of degeneration (for review see
(Hirsch and Hunot 2009)). This includes activation of
microglial cells secreting pro-inflammatory cytokines
and infiltration of CD4 and CD8 T lymphocytes as
evidenced post-mortem in the substantia nigra of pa-
tients with Parkinson disease (McGeer et al. 1988;
Brochard et al. 2009). Experimental models, mainly
developed in mice using the parkinsonian drug MPTP,
suggest the activation of both innate and adaptive im-
mune response is involved in neuronal degeneration as
blockade of these events prevents at least partially the
loss of dopamine neurons.
Several lines of evidence suggest oxidative stress
plays a very special role in the degeneration of mela-
nized dopamine in Parkinson disease, which are partic-
ularly sensitive to oxygen radicals (Hirsch et al. 1988).
Within dopaminergic neurons, oxidative stress is due in
part to a deficiency of complex-1 activity within mito-
chondria (Schapira et al. 1990). In line with this hypoth-
esis, complex-1 inhibitors such as MPTP, rotenone, and
the recently discovered annonacin can killed dopami-
nergic neurons in vitro and reproduce parkinsonism in
animals (Lannuzel et al. 2008; Champy et al. 2004;
Höglinger et al. 2003). Rotenone and annonacin are of
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great interest as they also produce α-synuclein and tau
accumulations within the degenerating neurons. Post
mortem analysis confirms that oxidative stress partici-
pates in neuronal degeneration through increased lipid
peroxidation (Dexter et al. 1986), protein carbonylation
(Alam et al. 1997a), and 8-hydroxyguanine formation
(Alam et al. 1997b), all of which have been reported in
the parkinsonian substantia nigra. Furthermore, oxida-
tive stress is amplified by a rise in iron concentration
(Hirsch et al. 1988; Sofic et al. 1988; Dexter et al. 1987).
The origin of this increase in nigral iron is not fully
understood but might be due to a dysregulation of iron
transport within the cells. Indeed, the divalent metal
transporter (DMT1) is over-expressed in Parkinson dis-
ease and animals with a mutated DMT1 (reducing its
iron transport capacities) were less sensitive to parkin-
sonian toxins (Salazar et al. 2008). Altogether, multiple
sources of evidence suggest oxidative stress, involving a
rise in iron and the subsequent accumulation of
misfolded proteins within dopaminergic neurons partic-
ipate in the degenerative process. This raises the tanta-
lizing hypothesis that reducing iron concentration in
Parkinson disease might reduce the evolution of the
disease. A recent clinical trial in France using the iron
chelator deferiprone actually provided encouraging sup-
port for this hypothesis (Devos et al. 2014) which will
be further tested (and hopefully confirmed) in an ongo-
ing European clinical trial.
There is also the possibility that diet and antioxidants
may affect the incidence or progression of Parkinson
disease. In Parkinson disease, protein damage and deg-
radation mediated by reactive oxygen species and a
positive feedback loop (Esteves et al. 2009) appear to
contribute significantly to the loss of dopaminergic cells
in the substantia nigra, leading to dopaminergic defi-
ciency in the striatum, and alpha-synuclein oligomeri-
zation. Conversely, administration of antioxidants (GSH
and coenzyme Q) decreased alpha-synuclein oligomer-
ization and thus neurotoxicity (Esteves et al. 2009).
Several studies have shown certain diets exhibited neu-
roprotective patterns against Parkinson disease. One
study showed an inverse relationship with Parkinson
disease and adherence to a Mediterranean-type diet
(Alcalay et al. 2012), while other studies showed that
high consumption rates of plant-based diet (such as
fruits, vegetables, legumes, whole grains, nuts) with fish
and poultry was inversely associated with Parkinson
disease risk when compared with a standard Western
diet characterized with more red meat, sweets, and fried
foods (Gao et al. 2007). Similar to other neurological
disorders covered, diet can play a large role in improv-
ing quality of life in patients with Parkinson disease and
offer a promising avenue of further study.
Exercise enhances neuroplasticity by targeting synaptic
energy metabolism and mitochondrial function
in Parkinson disease patients
Despite the brain’s high metabolic demand, it has little
reserve when substrates are limited. Failure to supply
neurons with energy can be severe, leading to neurotrans-
mitter dysfunction and cell death. The analyses of brain
tissues from a wide spectrum of neurodegenerative disor-
ders all implicate deficits in the mitochondria. Conse-
quently, mitochondria-targeted pharmacological therapeu-
tics have been tested. However, none have translated into
successful clinical treatments. Despite these challenges,
energy metabolism remains a viable therapeutic target. By
better understanding the underlying molecular and bio-
chemical changes in glucose metabolism within the brain,
including conditions of metabolic stress, such as transient
hypoxia, acute and chronic injury, and degenerative dis-
eases, may provide better direction of targeted therapies.
Over the past several years, exercise has become
attractive as a non-pharmacological and inexpensive
treatment modality for many brain disorders. For exam-
ple, many Parkinson disease patients incorporate aspects
of physical activity in their standard of care. Small
studies and patient reports support the benefits of exer-
cise in improving quality of life, optimizing drug treat-
ment, and possibly modifying disease progression. Re-
search in animal models highlight the beneficial effects
of exercise, and further our understanding of the under-
lying molecular mechanisms. Even in light of these
major advancements, major gaps still exist.
The following studies highlight the hypothesis that
physical activity in the form of different types of exer-
cise (aerobic versus skill-based) is beneficial due to its
circuit specific effects on synaptic connectivity (a major
component of neuroplasticity). Specifically, the effects
of exercise on energy metabolism at the synapse, its
ability to modulate synaptic mitochondrial function,
glucose uptake, astrocyte-neuron coupling, and the
mechanisms that link central nervous system (CNS)
and peripheral (muscle) activity. Together, a greater
understanding of these processes may improve pharma-
cological drug development, guide clinicians on patient-
appropriate exercise, especially in treatingmotor deficits
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associated with Parkinson disease, and provide insight
on long-term exercise for optimal brain function, includ-
ing the later stages of ageing.
Effects of exercise in an animal model of Parkinson’s
disease
Epidemiological studies have shown that exercise and
other forms of physical activity reduce the incidence of
Parkinson disease, Alzheimer disease, and mild cognitive
impairment (MCI) (Chen et al. 2005; Ohman et al. 2016).
Animal models utilizing the dopamine depleting agents
MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
and 6-OHDA (6-hydroxydopamine) have been instru-
mental in our understanding.
However, a limitation of these studies is lack of con-
sensus on exercise parameters employed in mouse stud-
ies, including duration, velocity, intensity, and level of
skill. However, one common component is exercise in-
troduced prior to or during the active phase of toxin-
induced cell death protects against midbrain dopaminer-
gic neuron cell death and the depletion of striatal dopa-
mine. A number of mechanisms may mediate neuropro-
tection including (i) elevation of neurotrophic factors
such as BDNF (brain-derived neurotrophic factor), (ii)
increased resilience of mitochondria, (iii) reduced bio-
availability of toxins due to alterations in peripheral pro-
cessing (liver metabolism), transport across the blood
brain barrier, uptake into dopaminergic neurons (through
reduced expression of the dopamine transporter, DAT), or
storage/sequestration via vesicular uptake through
VMAT2 (vesicular monoamine transporter) into vesicles.
Dopaminergic toxin-induced models can also be
used to study neurorestoration: the effects of exercise
on neuronal connectivity following toxin-induced cell
death. One area of interest is understanding the under-
lying mechanism by which exercise, in the form of
intensive treadmill running, leads to the restoration of
motor behaviors in the MPTP-lesioned mouse model,
collectively termed neuroplasticity (Fisher et al. 2004).
In summary, exercise led to elevated striatal dopamine
D2 receptor expression, reduced striatal DAT expres-
sion, elevated release of dorsolateral striatal dopamine,
altered expression of the ionotropic glutamate receptor
subunits GluA1 and GluA2, and restoration of dendritic
spine density on striatal medium spiny neurons (MSNs)
(Fisher et al. 2004; Petzinger et al. 2007; Toy et al. 2014;
Kintz et al. 2013; VanLeeuwen et al. 2010). These
results indicate circuit specific changes leading to
improved motor behavior. The concept of circuit-
specific changes is further supported by recent studies
examining alterations in regional cerebral blood flow
(rCBF) with exercise. Specifically, elevation in cortical
rCBF in the PFC, with enhanced distribution upon
skilled exercise compared to aerobic exercise (Wang
et al. 2015).
While exercise provides general brain health, we are
interested in understanding how exercise can be targeted
to specific brain circuits, especially those affected in
neurological disorders like Parkinson disease. More-
over, different types of activity have variable effects.
For example, types of exercise with greater skill and
learning components, which engage cognitive circuits,
show greater benefit than those which are purely aerobic
and limited cognitive engagement (Voelcker-Rehage
et al. 2011). This is important in patients with Parkinson
disease where cognitive deficits are evident in the early
stages of disease and may contribute to the degenerative
process and lead to the progression of severe motor
deficits. Interestingly, early synaptic changes with exer-
cise in the MPTP-lesioned mouse model originate from
cortical afferents, especially the corticostriatal circuit
connecting the cerebral cortex with the striatum (cau-
date-putamen). These observations, along with the fact
that deficits in cognition can interfere with gains in the
benefits of exercise, highlight the importance of circuit
specific targets that must be engaged to enhance im-
provements in motor behavior. In other words, mecha-
nisms of neuroplasticity enhanced by activating cogni-
tive circuits are critical for targeting improvement in
motor circuits.
Therefore, amajor gap in our knowledge is the identity
of the molecular mechanisms by which exercise, espe-
cially forms of exercise targeting corticostriatal afferents,
lead to improved motor behaviors and modify disease
progression. One attractive hypothesis is the role of me-
tabolism as it links neuronal activity-induced changes in
blood flow, breakdown of energetic substrates to the
expression of genes and proteins involved in angiogene-
sis and synaptogenesis. Central to this hypothesis are the
biosynthetic mechanisms involved in energymetabolism,
mitochondrial function, and synaptic connectivity.
Brain energy metabolism in Parkinson’s disease
The brain is the most metabolically demanding organ in
the human body (Attwell and Laughlin 2001). However,
unlike most peripheral tissues, the brain has limited
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metabolic flexibility such that it relies almost exclusive-
ly on glucose (and under specific conditions, lactate) as
its substrate for energy metabolism. This highlights the
brain’s dependency on a continuously available exoge-
nous fuel supply. In the brain, glucose is metabolized
through four principle biochemical pathways: (i) glycol-
ysis, (ii) oxidative phosphorylation (OXPHOS), (iii) the
pentose phosphate pathway (PPP), and (iv) glycogene-
sis. Importantly, each of the different cell types within
the brain (neurons, astrocytes, microglia, oligodendro-
cytes) has its own distinctive metabolic profile. For
example, neurons have a high energy expenditure, due
to the establishment and maintenance of the membrane
resting potential. In addition, neuronal computation is
extremely energetically demanding, with most energy
consumption occurring at the synapse (Harris et al.
2012). This demand is reflected by the high number of
mitochondria preferentially localized to the pre- and
post-synaptic terminals, implicating the close relation-
ship between energy production and its demand (Wong-
Riley 1989). Mitochondria not only produce ATP, but
are involved in other molecular functions, including
buffering the cellular calcium influx and the generation
of low levels of reactive oxygen species necessary for
normal metabolic homeostasis.
Loss of mitochondrial function at synapses can lead
to synaptic deregulation and loss of brain connectivity.
Historically, the study of neurodegenerative disorders
has correlated alterations of mitochondrial function with
synaptic changes. With respect to Parkinson disease, the
discovery of MPTP-induced parkinsonism shed light on
mitochondria as a contributor to disease process
(Langston et al. 1983; Langston 2017). Since then, the
involvement of mitochondria has been shown to be
much more complex, with defect in: trafficking, biogen-
esis, mitophagy, activation of apoptosis, oxidative
stress, and calcium buffering capacity (Mounsey and
Teismann 2011).
In addition, the mechanisms by which familial forms
of Parkinson disease occur have increased our insight.
These familial forms of Parkinson disease include ge-
netic mutations in alpha-synuclein (SNCA), DJ-1,
PINK1, Parkin, LRRK2, and UCH-L1. Many of these
genes play key regulatory roles in mitochondrial func-
tion and synaptic health, especially those localized to the
nigrostriatal and corticostriatal pathways. The PINK1/
Parkin pathway acts as a mitochondrial Bquality-
control^ pathway, due to its role in Drp1-mediated
mitochondrial fission.Mutations in this genetic pathway
are implicated in Parkinson disease characteristic dopa-
minergic degeneration (McWilliams and Muqit 2017).
Similarly, loss of DJ-1 causes accumulation of dysfunc-
tional mitochondria at the synapse by disrupting lyso-
somal homeostasis (Krebiehl et al. 2010). LRRK2 mu-
tations act as an underlying cause of mtDNA damage in
neural cells, the downstream effects impacting calcium
imbalance, oxidative stress, and dendritic shortening.
Alpha-synuclein impairs normal mitochondrial fission
(biogenesis) (Xie and Chung 2012).
Exercise is inherently associated with metabolism
since increased metabolic expenditure demands require
increased ATP. At the neuron, energy demands rise with
increased firing of action potentials and increased syn-
aptic neurotransmission. These metabolic challenges are
addressed by enhanced delivery of glucose and lactate to
meet the demands for greater ATP production. In addi-
tion, neuroprotective strategies are also activated
throughmetabolic responses that help to protect neurons
from acute bouts of oxidative stress; mitochondria can
enter a state of senescence while alternative sources of
energy production are activated—including aerobic gly-
colysis for the production of ATP (Barros 2013).
In addition to increased energy requirements, the
brain also engages in anabolic processes by which struc-
tural proteins and other macromolecules necessary for
neuroplasticity including the synthesis of nascent recep-
tors, axonal and dendritic scaffolding proteins, and other
morphological changes are produced. The metabolic
pathways, either directly or indirectly, contribute in
shuttling small molecular substrates such as glucose,
lactate, and other molecules like lipids and amino acids
in supplying the needed structural components for
neuroplasticity. Evidence is now emerging that exercise,
specifically forms of exercise that target corticostriatal
circuits, can promote metabolic changes that can harness
neuroplasticity.
Exercise activates specific circuits in the brain, in-
cluding those involved in motor control, linking the
cerebral cortex, basal ganglia, thalamus, and cerebel-
lum. Enhanced neuronal activity is associated with in-
creased metabolic demand and elevated levels of local
cerebral glucose utilization. Consistent with this, several
groups have reported increased expression of the glu-
cose transporters GLUT1 (endothelial- and astrocyte-
specific) and GLUT3 (neuron-specific) in motor control
regions following treadmill exercise (Allen and Messier
2013; Takimoto and Hamada 2014; Kinni et al. 2011).
Although there have been no reported changes in
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GLUT1 expression in the Parkinson disease brain, it has
been shown that mitochondrial dysfunction and reactive
oxygen species accumulation can impair cellular glu-
cose uptake and an inadequate glucose supply can have
deleterious effects on dendritic morphology and impair
synaptic plasticity, which underlie aspects of Parkinson
disease pathology (Gandhi et al. 2009). Therefore, by
driving activation of circuits affected in Parkinson dis-
ease, exercise imposes a metabolic challenge, which is
met by an adaptive upregulation of glucose transporters
to improve glucose availability and to support synaptic
function. In addition to changes in GLUT1 expression,
there is also an activation of enzymes involved in energy
production including dehydrogenases for lactate and
glucose and others within the TCA cycle.
In recent decades, lactate has emerged from largely
being considered as a metabolic waste product to an
important supplemental brain energy substrate and signal-
ing molecule. At rest, blood-derived lactate (~ 1 mM)
provides 8–10% of total brain energy requirements
(Smith et al. 2003; Boumezbeur et al. 2010). Yet, during
moderate-to-vigorous aerobic exercise, blood lactate
levels can increase by up to 10-fold, supplementing brain
energy requirements, up to 25% of the overall demand
(van Hall et al. 2009). Complementing elevated blood
lactate levels following bouts of aerobic exercise, specific
regional up-regulation of lactate transporters have been
found in the cortex, hippocampus, and hypothalamus,
indicating a preferential utilization of peripheral lactate
during supra-physiological conditions (Takimoto and
Hamada 2014). Furthermore, it has been suggested that
the immediate energy requirements of sustained synaptic
activity are at least, in part, fueled by the complete oxida-
tion of astrocyte-derived lactate (Hall et al. 2012). The
potential central role of astrocytes in linking metabolism
and neuroplasticity is highlighted in the next sections.
Effects of exercise on brain mitochondrial function
in Parkinson disease
It has been well-established that aerobic exercise training
is highly beneficial to muscle mitochondria efficiency.
Surprisingly, much less is known about the effects of
exercise on mitochondria in the brain, either in neurons
or glia. As mentioned above, neuronal mitochondria are
preferentially localized to the synapse and are responsi-
ble for supplying the energy demands of synaptic func-
tion in active neuronal circuits. In normal ageing and in
neurodegenerative disorders such as Parkinson disease,
there are a number of mitochondrial alterations that can
result in their dysfunction, including the following: de-
creased activity of the ETC and other enzymatic proteins,
including those involved in controlling oxidative stress
and calcium buffering, accumulation of mtDNA muta-
tions, altered biogenesis, and dysregulation of mitophagy
(Schapira et al. 1990). Exercise represents a potentially
important non-pharmacological approach to target mito-
chondrial function at the synapse with the goal to facil-
itate synaptic integrity and to promote synaptic plasticity.
One means by which exercise can modulate brain
mitochondria is through improved respiratory chain func-
tion. For example, regular physical activity has been
reported to increase enzymatic activity of ETC Com-
plexes I, III, and IV (Navarro et al. 2004). Furthermore,
improved motor behaviors following exercise in the
MPTP mouse model of Parkinson disease is associated
with enhancedmitochondrial function (Lau et al. 2011). In
addition to affecting mitochondrial ATP production effi-
ciency, exercise can also regulate mitochondrial density at
the synapse. Chronic physical exercise training, such as
treadmill running, up-regulates the genes for silent infor-
mation regulator 1 (SIRT1) and peroxisome proliferator-
activated receptor-γ coactivator 1-alpha (PGC-1α). These
proteins regulate mtDNA copy number in several brain
regions including the PFC, striatum, and hippocampus, as
well as cascades of enzymes involved in energy metabo-
lism, biogenesis, regulation of oxidative stress,mitophagy,
and apoptosis (Steiner et al. 2011; Gerhart-Hines et al.
2007). It is of interest to note that SIRT1 and PGC-1α are
the focus of a number of pharmacological agents to en-
hance mitochondrial health and one can speculate that
efficacy of any drug intervention may be enhanced with
the synergistic application of exercise.
Astrocytes, exercise, and neuroplasticity in Parkinson
disease
Astrocytes fulfill important tasks, including mediating
brain vasculature, providing energetic substrates (such
as lactate) for neighboring neurons, and recycling synap-
tic glutamate following neuronal activity. The latter ac-
tivity, the glutamate-glutamine cycle, is a cornerstone of
astrocyte-neuron coupling and serves as a key mediator
of neuronal activation. With astrocytic processes
enveloping neuronal synapses, the astrocytic excitatory
amino acid transporter 1 and 2 (EAAT1 and 2) serve as
sensors of neuronal activation (and subsequent glutamate
release) and facilitate uptake of glutamate from the
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synaptic cleft (Rothstein et al. 1994). This glutamate is
then converted into glutamine, which is subsequently
recycled back to neurons for conversion into glutamate
and repackaged into vesicles for future synaptic events.
The uptake of glutamate is an ATP-dependent process,
due to increased sodium-potassium-ATPase activity to
meet ionic displacement during glutamate uptake
(Khatri and Man 2013), thus inducing shifts in astrocytic
metabolism to meet the neuroenergetics demands of
glutamate-glutamine cycling.
This example of astrocyte-neuron coupling forms the
basis for the astrocyte-neuron lactate shuttle (ANLS)
hypothesis which postulates that (i) excitatory neuro-
transmission at the glutamatergic synapse (glutamate/
glutamine cycle) drives glucose uptake from the circula-
tion via GLUT1 expressed in microvascular endothelial
cells and astrocytes, (ii) glucose is preferentially metab-
olized via aerobic glycolysis in astrocytes to yield lactate,
and (iii) lactate is shuttled from astrocytes to neurons via
monocarboxylate transporters (MCTs) where it is con-
verted back to pyruvate and enters the TCA cycle in
mitochondria (Pellerin and Magistretti 1994). Astrocyte-
specific metabolic changes during high levels of neuro-
nal activity serve not only to provide energy to excitatory
neurons through the ANLS, but also a necessary meta-
bolic pivot to continue cycling glutamate.
Important for the facilitation of exercise-induced
neuroplasticity, the ANLS represents a model, which cou-
ples neuronal activity and the rapid delivery of energy
substrates to the synapse. Preliminary data suggest that
exercise may target synaptic metabolism by up-regulating
the expression of ANLS components, such as lactate
dehydrogenase and MCT2 (neuron specific lactate trans-
porter), in the striatum, following a single bout of treadmill
exercise (unpublished data, Halliday et al.). Interestingly,
cell-specific overexpression of GLUT1 (in astrocytes) and
MCT2 (in neurons) has been shown to be protective
against glutamate excitotoxicity. Taken together, these
findings suggest that exercise may improve astrocyte-
neuron cooperation to facilitate lactate delivery required
by active synapses in order to supplement the increased
metabolic demand, and thus support synaptic function and
plasticity. Disruption of astrocytic lactate impairs long-
term memory formation and is rescued by administration
of exogenous lactate, but not glucose (Suzuki et al. 2011).
Intra-hippocampal infusions of lactate enhance working
memory and blocking neuronal uptake of lactate impairs
memory formation in rats (Newman et al. 2011). Further,
neuronal uptake of lactate induces activation of immediate
early genes (IEGs), including Zif-268, c-Fos, and Arc,
implicating lactate in neuroplasticity processes (Yang
et al. 2014). These findings, and others, demonstrate the
critical role of astrocyte-derived lactate serving as an
important energy substrate in synaptic plasticity.
The close relationship between astrocytes and neurons
and their health is paramount to adaptive neuroplasticity
and synaptogenesis. In a number of neurodegenerative
disorders, astrocytic activation has been well documented
in terms of astrocyte morphology and elevated glia fibril-
lary acidic protein (GFAP) expression, a marker of astro-
cyte inflammation. Indeed, neuronal expression of lactate
dehydrogenase subunit 1 (LDH-1) demonstrates a cell-
specific ability to oxidize lactate (Bittar et al. 1996). An
outcome that may prove beneficial in supplying high
energetic demands during oxidative stress when glucose
is selectively shunted toward the PPP tomaintain neuronal
antioxidant status. Additionally, overexpression of lactate
dehydrogenase in vitro provided protection against
amyloid-β exposure by shifting neuronal energetics from
OXPHOS to aerobic glycolysis, ensuring cellular resis-
tance (Newington et al. 2012). Dysfunctional astrocytes
can have extensive molecular consequences including
reduced lactate production to supply neurons, dysfunction
of the BBB at astrocyte end feet, and diminished support
through factors such as BDNF. Thus, astrocytic integrity
may serve as an early indicator of brain disease and may
emerge as an important therapeutic target.
A potential role for hypoxia-inducible factor 1
in Parkinson disease
When local metabolic demand through elevated neuro-
nal activity exceeds that of available energy resources,
highly conserved transcriptional programs are activated
to increase oxygen delivery, optimize cellular metabo-
lism, increase metabolic capacity, and establish homeo-
stasis. The wide spectrum ofmolecular targets necessary
for a successful response indicates the importance and
complexity of changes that are necessary to survive
challenges like metabolic demand. One such candidate
is the hypoxia-inducible factor-1α (HIF-1α), a member
of the HIF family of proteins. HIF-1α is a cytoplasmic
multimeric protein that is constitutively expressed. Un-
der normoxic conditions, HIF-1α is hydroxylated and
subsequently ubiquitinated for targeted proteasome deg-
radation. Under conditions of low oxygen, such as the
transient hypoxia state during intensive exercise, HIF-
1α is stabilized, and translocates into the nucleus, and in
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complex with the protein HIF-1β, forms an active tran-
scription factor that binds to the hypoxia response ele-
ment (HRE) found in the promoter region of a large
number of genes including many responsible for glu-
cose and lactate transport, energy metabolism, angio-
genesis, mitochondria function, and synaptogenesis.
It has been suggested that one of the potential benefits
of exercise in the MPTP-lesioned mouse model is
through the activation of HIF-1α (Smeyne et al. 2015).
Thus, the role of HIF-1α in neural tissues is not restricted
to the regulation of energy metabolism through oxygen
sensing but has a potentially wider role in regulating
complex molecular events including neurogenesis, an-
giogenesis, and mitochondrial function (biogenesis),
which are important for exercise-induced neuroplasticity
and synaptogenesis (Zhu et al. 2005; Shweiki et al. 1992;
Correia et al. 2011; Petzinger et al. 2015). Therefore, one
potential mechanism may be that exercise, through in-
creased cellular metabolic energy demand, activates the
HIF-1α transcriptional program, which in turn supports
synaptic strength and connectivity during motor learning
in the Parkinson disease brain (Fig. 4).
It is interesting to note that transcription factors such
as HIF-1α, which is tightly regulated by oxygen de-
mand, are also regulated by other factors that can
Bsense^ metabolic demand in neuronal circuits. These
other factors include reactive oxygen species including
superoxide, the glutamate-glutamine cycle, nitric oxide,
and potassium levels all highlighting the potentially
complex and important role played by such central
regulators.
It is well-established that exercise is beneficial in
both treating and preventing many disorders in the dis-
eased and ageing brain. It is necessary to identify the
underlying molecular mechanism such that novel treat-
ments can target specific disorders. In terms of
Parkinson disease, evidence indicates that circuit specif-
ic pathways linking cognitive and motor circuits are
critical in enhancing neuroplasticity to generate benefits
in complex behavior like movement. These studies
highlight the potential link between energy metabolism
and neuroplasticity. Circuit specific activation of neuro-
nal pathways leads to changes in glucose and lactate
metabolism, altered mitochondria function, and
Fig. 4 Changes in metabolism involving the corticostriatal path-
way lead to improved circuit specific changes. The left panel
highlights some of the features of the corticostriatal circuit in
sedentary animals when synaptic activity is low. Glucose serves
as the primary energy substrate in neurons catabolized to pyruvate
by glycolysis and shuttled into mitochondria to the TCA cycle and
ETC for oxidative phosphorylation. Mitochondria (small check-
ered ovals) generate ATP via oxidative phosphorylation. Expres-
sion of regulatory factors such as HIF is attenuated under
normoxia. The right panel highlights changes in the corticostriatal
circuit with exercise. Neuronal activation leads to significant met-
abolic changes at the synapse including reduced glucose and
depletion of oxygen. Activation of astrocytes leads to an increase
in aerobic glycolysis elevating levels of lactate from glucose
substrates. Lactate is transported to neurons via the astrocyte
neuron lactate shuttle (ANLS) for conversion to pyruvate provid-
ing an alternative substrate source for mitochondria energetics.
Astrocytes located near synapses may have a unique function in
neuroplasticity in that they can detect increased activity through
changes in potassium release, glutamate neurotransmission, in-
creased oxidative stress through ROS, and depletion of oxygen
and glucose. It has yet to be established how these mechanisms
may or may not differ from those astrocytes metabolically associ-
ated with neuron cell bodies for example. Changes in blood flow
are both acute due to dilation by nitric oxide and prostaglandins
and chronic due to increased expression of factors such as HIF-1α
dependent VEGF. Increased blood flow and peripheral effects of
exercise elevate blood glucose and lactate levels that can be
transported to astrocytes and neurons via transporters including
MCTs and GluTs
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activation of cascades including those through regula-
tors like HIF-1α that can induce genes and proteins
necessary for angiogenesis, synaptogenesis, and other
components of neuroplasticity. While this may not rep-
resent a cure for disorders like Parkinson disease, it does
implicate an important therapeutic target to complement
pharmacological strategies and if implemented early
may in fact modify disease progression.
Joints and inflammation
Joints and mobility
Freely movable diarthrosis or synovial joints have the
greatest range of motion of any joint in the body. The six
types of synovial joints are the pivot, hinge, saddle,
planar, condyloid, and ball-and-socket joints. Pivot
joints include the atlantoaxial joint between the atlas
and axis of the neck. Hinge joints are found in the
interphalangeal joints of fingers and toes. Saddle joints
occur between the trapezium and metacarpal I–thumb
joint. Planar joints are found between the navicular and
second cuniform of the ankle. Condyloid (or gliding)
joints occur between the radius, scaphoid, and lunate
bones of the wrist. Ball-and-socket joints are found in
the hips and shoulders.
When diarthrosis or synovial joints are healthy,
movement is smooth and painless. In contrast, when
joints become inflamed and suffer damage to key com-
ponents, movement becomes difficult and painful. Some
common diseases or conditions that involve joint pain
and inflammation are rheumatoid arthritis, systemic lu-
pus erythematosus, and osteoarthritis, which are
discussed below.
Rheumatoid arthritis.
Rheumatoid arthritis was first described in 1800. Initial-
ly it was felt to be a variant of gout, but this idea was
proven wrong when excess uric acid was found to be
involved in gout, but not in rheumatoid arthritis (Garrod
1859). Various theories have been postulated on the
etiology of rheumatoid arthritis from pathogens includ-
ing bacteria, as well as various viruses as potential
triggers (Fox 2005); however, a direct link has yet to
be determined. A genetic component clearly plays a role
as there is a clear association between a group of major
histocompatibility complex cell surface receptors and
disease predilection (Reveille 1998). An increased level
of reactive oxygen species formation and oxidative
stress has also been found in rheumatoid arthritis. Intra-
cellular formation of reactive oxygen species, lipid per-
oxidation, protein oxidation, and DNA damage have all
been found in the blood of rheumatoid arthritis patients
(Mateen et al. 2016; Chuang et al. 2012), so there is
clear evidence that oxidative stress occurs in rheumatoid
arthritis patients. Lunec et al. (Lunec et al. 1985) pro-
posed that oxidative damage to IgG generated protein
aggregates that can activate neutrophils and set up a
Bvicious cycle^ (Halliwell 1995) of free radical produc-
tion. A more recent clinical target to attempt to control
rheumatoid arthritis is tumor necrosis factor (TNF).
Kageyama et al. (Kageyama et al. 2008) have reported
that treatment with infliximab, an anti-TNF biologic,
played an essential role as an antioxidative agent against
advanced glycation end-product (AGE) formation, oxi-
dative DNA damage, and lipid peroxidation.
Systemic lupus erythematosus
Systemic lupus erythematosus is a complex inflamma-
tory autoimmune disease whose etiology remains large-
ly unknown. It involves many organs and presents in a
varied way, mimicking many other diseases including
malignancies and infections. Lupus typically presents
with painful, swollen joints so that the disease is some-
times confused with arthritis. Lupus-related joint pain
and stiffness are typically worse in the morning. In early
stages of systemic lupus erythematosus, joint pain is
typically mild, but then increases significantly as the
disease progresses (Lahita 2011). The hallmark of sys-
temic lupus erythematosus is the presence of diverse
autoantibodies that are directed at a varied group of
self-antigens (Boyd 1997). Many mechanisms have
been implicated in its origin and disease progression.
One of the mechanisms implicated is oxidative stress
and free radicals. Uncontrolled oxidative stress is felt to
contribute to modifications of cellular protein, lipid, and
DNA. Biomarkers have been identified that may poten-
tially be useful in measuring disease activity, and whose
control could be an approach to diminish end-organ
damage (Shah et al. 2014). Oxidative stress, for exam-
ple, leads to lipid peroxidation these products have been
implicated in the pathogenesis of systemic lupus erythe-
matosus (Otaki et al. 2010). Autoantibodies are typically
present several years prior to disease activity in systemic
lupus erythematosus. Inflammation, infection, drugs,
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and environmental factors induce formation of
neoantigens with involvement of reactive oxygen spe-
cies. An attempt to determine how these factors trigger
disease, in a subset of the population, is still under
scrutiny. What is clear though is that oxidative damage
is involved in diseases such as systemic lupus erythe-
matosus. Formation of reactive oxygen species along
with enzymatic and nonenzymatic control of these po-
tentially harmful molecules becomes an ongoing pro-
cess leading to disease (Kurien et al. 2012). Antioxidant
enzymes may be the target of antibodies resulting in a
loss of a delicate balance.
Osteoarthritis
Osteoarthritis (OA) is a major cause of severe joint pain,
disability, and diminished quality of life in ageing pop-
ulations. Breakdown of the extracellular matrix of the
articular cartilage is a major factor in development and
progression of osteoarthritis. The exact mechanisms
leading to this cartilage change have not been defined,
but loss of glucosamine and hyaluronic acid are early
findings, which may be genetically determined. Other
early observations include cell loss, elevated oxidative
stress, and increased expression of inflammatory medi-
ators. Chronic age-related conditions such as osteoar-
thritis demonstrate de-regulation of common molecular
and cellular mechanisms (Ladislas 2000). Some of these
changes involve impaired autophagy, diminished clear-
ance of apoptotic bodies, protein misfolding, and oxi-
dative stress which (in turn) can activate pro-
inflammatory pathways that are felt to contribute to
degeneration of articular cartilage. Elevated serum
levels of pro-inflammatory cytokines such as IL-1, IL-
6, IL-18, TNFα, and CRP have been shown to increase
with ageing (Krabbe et al. 2004; Cesari et al. 2004).
Elevated levels of damaged proteins, a result of the
increased oxidative stress, have been found in synovial
fluid and plasma of osteoarthritis patients, and have
been used as biomarkers for disease progression
(Ahmed et al. 2016). The articular cartilage is present
in joints to support and distribute mechanical loads,
allowing motion while avoiding erosion. Most of the
articular cartilage consists of thick extracellular matrix,
whereas chondrocytes, the only cell type in the articular
cartilage, represent only 5% of the joint mass. Ageing
results in cell senescence (Musumeci et al. 2015), loss of
chondrocyte phenotype and thus abnormal remodeling
of the extracellular matrix (Quintero et al. 1984; Lotz
et al. 2010), and age-related changes in the extracellular
matrix (Bhosale and Richardson 2008). The interaction
of all of these changes is still poorly understood and
further investigation needed to determine age-related
therapeutic targets that may eventually lead to treatment
and/or prevention of osteoarthritis in the elderly.
Bone and macrophages
Bone is a dynamic structure dependent upon the con-
stant activities of osteoblastic bone formation and oste-
oclastic bone resorption. If these two actions are not in
balance, pathology ensues (Boyle et al. 2003; Nohl
1993; Wauquier et al. 2009; Vaananen et al. 2000).
There is growing evidence indicating increased reactive
oxygen species-derived oxidative stress, which in-
creases with the onset of an inflammatory state or with
ageing, can adversely affect bone (Wauquier et al. 2009;
Altindag et al. 2008; Garrett et al. 1990; Ozgocmen et al.
2007). Abnormally high levels of oxidants and/or low
levels or activity of antioxidants can specifically impair
the osteoblastic/osteoclastic balance. Under physiologi-
cal conditions, cells derived from bone marrow macro-
phages, coined osteoclasts, produce oxidant species that
facilitate the destruction of calcified tissue, thus partic-
ipating in bone remodeling (Silverton et al. 1995; Yang
et al. 1998).
Understanding which factors drive osteoclast activity
and differentiation is important when studying diseases
characterized by heightened bone resorption relative to
formation, such as osteoporosis. In the last decade,
studies have indicated that reactive oxygen species,
including superoxide and hydrogen peroxide, are crucial
components that regulate the differentiation process of
osteoclasts.
Oxidative stress and osteoporosis
A normal balance between oxidants and antioxidants is
necessary for the correct equilibrium between osteoblast
and osteoclast activities, respectively (Sheweita and
Khoshhal 2007). In particular, when the production of
reactive oxygen species by osteoclasts overwhelms the
natural antioxidants defense mechanisms, the concomi-
tant oxidant stress may lead to bone loss and hence to
osteoporosis (Sheweita and Khoshhal 2007). However,
the exact biochemical and cytological basis of the events
finally responsible for bone resorption are still debated.
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It has been suggested that an enhanced osteoclastic ac-
tivity may increase the superoxide anion generation and/
or inhibit superoxide dismutase (SOD) and glutathione
peroxidase activities with concomitant bone destruction
(Sheweita and Khoshhal 2007). Indeed, early evidence
for reactive oxygen species participation in bone reab-
sorption has been described (Garrett et al. 1990), wherein
the addition of the superoxide-producing enzyme, xan-
thine oxidase, in vivo and in vitro, resulted in increased
osteoclast numbers and activity. This effect was attenu-
ated when SOD was added; however, no change was
seen upon the addition of catalase, which scavenges
H2O2. Therefore, the authors concluded that the super-
oxide radical rather than H2O2 or ·OH was important in
mediating the enhanced bone resorption. Subsequent
studies also found that O2
·– production was present with-
in the osteoclast and suggested that it may be derived
from nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase localized to the bone–osteoclast in-
terface within the osteoclast ruffled border (Key et al.
1994; Steinbeck et al. 1994). Blockage of NADPH ox-
idase by diphenylene iodonium resulted in decreased
O2
·– production and bone resorption (Yang et al. 1998;
Darden et al. 1996). Other studies, however, indicated
that rather than O2
·–, H2O2 was the primary culprit
behind osteoclast formation and activity (Bax et al.
1992; Fraser et al. 1996; Kim et al. 2006).
In a published case control study on 94 subjects aged
> 60 years (50 healthy and 44 with osteoporosis), where
total antioxidant status, plasma lipid peroxides, SOD,
and glutathione peroxidase (GPx) activities were mea-
sured, oxidative stress appeared as an independent risk
factor for osteoporosis linked to the increase of SOD/
GPx ratio (Sanchez-Rodriguez et al. 2007). Further-
more, since increased osteoclastic activity and decreased
osteoblastic activity were shown to be associated with
an imbalance between oxidant and antioxidant status
plasma biomarkers in postmenopausal osteoporosis, an-
tioxidant supplementation has been proposed as a novel
therapeutic strategy in this disease (Altindag et al.
2008). In this context, α-lipoic acid inhibited osteoclast
differentiation (Kim et al. 2006), while lycopene was
shown to reduce either oxidative stress or levels of bone
turnover markers in postmenopausal women, reducing
the risk of osteoporosis (Rao et al. 2007). These findings
highlight the importance of nutrition in the maintenance
of healthy bones, in particular with the benefit of D-
vitamin supplementation. Noticeably, since the lowest
incidence of osteoporosis in European countries has
been reported in the Mediterranean area, it may be that
the BMediterranean lifestyle^ that implies the consump-
tion of foods containing a complex array of naturally
occurring bioactive molecules with antioxidant, anti-
inflammatory, and alkalinizing properties, can contrib-
ute to a Bbone-sparing^ effect (Puel et al. 2007).
Oxidative stress, NADPH oxidase activity,
and osteoclast function
Nox (NADPH oxidase) is a widely distributed enzyme
in the body that catalyzes the generation of superoxide
anion from molecular oxygen. This enzyme system can
also generate O2
·– in osteoclasts (Yang et al. 1998;
Steinbeck et al. 1994). One member of the Nox family,
Nox4, is well expressed in kidneys, but is also abundant
in the vascular system and in many other tissues and
cells (Krause 2004), including osteoclasts (Yang et al.
2004), where its activity appears to be related to bone
resorption. Abrogation of the normal level of Nox4
expression in osteoclasts inhibits both osteoclastic O2
·–
production and bone resorption (Yang et al. 2001). An
increase or decrease in superoxide anion production by
osteoclasts is associated with, respectively, stimulated or
inhibited osteoclastic bone resorption (Garrett et al.
1990; Berger et al. 2001; Ries et al. 1992).
Of note, O2
·– produced by osteoclasts in an extracel-
lular compartment and even in the absence of other
enzymes is capable of degrading bone matrix proteins
such as osteocalcin, which break up into small peptides
post exposure (Key et al. 1994).
Oxidative stress, nitric oxide and bone remodeling
Nitric oxide (NO·) generated from arginine by NO syn-
thase (NOS) is a free radical involved not only in vas-
cular relaxation, platelet aggregation, neurotransmis-
sion, and immune system regulation (Moncada and
Higgs 1993), but also in bone metabolism and function.
Constitutive NOS (cNOS) is widely expressed in bone
marrow stromal cells, osteoblasts, osteocytes, and oste-
oclasts (Helfrich et al. 1997), while inducible NOS
(iNOS) has been observed in fetal bone (Hukkanen
et al. 1999)—suggesting a role in skeletal development,
but not constitutively in normal adult bone (Fox and
Chow 1998). Osteoblasts stimulated with proinflamma-
tory cytokines and/or endotoxin in vitro express iNOS
(van't Hof and Ralston 1997), but it is still not clear
whether osteoclasts express this enzyme. NO· can
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influence osteoblast or osteoclast activity and therefore
bone remodeling.
Osteoblasts and osteocytes under mechanical strain
and shear stress conditions produce large amounts of
iNOS-mediated NO· that may augment bone gain by
inhibiting prostaglandin-induced bone resorption
(Ralston and Grabowski 1996). It has also been reported
that osteocytes show a greater increase in NO· produc-
tion as a result of mechanical loading than osteoblasts.
This supports the theory that osteocytes are the main
sensors and effectors of mechanical stress in bone (van't
Hof and Ralston 2001).
Proinflammatory cytokines, such as IL-1 or
TNF-α further increase NO· levels in bone tissues with
subsequent potent inhibitory effects on osteoblast dif-
ferentiation and growth. This may be eventually ex-
plained by the pro-apoptotic effects of NO· on osteo-
blasts (Armour et al. 2001), through a cGMP-dependent
pathway (Mancini et al. 2000). This observation may
explain the inhibitory effects of pro-inflammatory cyto-
kines on bone formation.
Since chronic inflammation is a hallmark of ageing,
this parameter may play a role in bone healing by
altering bone fitness. This may explain the high inci-
dence of hip fracture in elderly patients. Indeed, with the
ageing of the population, hip fractures are a growing
issue. At least half of hip fracture patients never regain
their previous function (Stevens and Olson 2000), and
post-hip fracture mortality at 1 year remains as high as
33% (Roche et al. 2005). The factors influencing recov-
ery from hip fracture are poorly understood although
persistent inflammation related to oxidative stress is a
common feature in these patients.
When bone fracture occurs, the damaged tissues
generate a remarkable amount of active radicals that
are formed from the molecular interactions between
embedded collagen strands and the mineral phase, and
this phenomenon may facilitate bone healing (Symons
1996). As well, particular relationships between reactive
oxygen species, hormones, and vitamins tie into bone
metabolism. Estrogens, whose antioxidant activity is
pivotal in protecting women of reproductive age from
cardiovascular disease, stimulate osteoblastic activity
through specific receptors, thus favoring bone growth.
Therefore, primary estrogen deficiency in postmeno-
pausal women can, through a loss of antioxidant poten-
cy, depress osteoblastic activity and indirectly enhance
osteoclastic activity, leading to a reduction in skeletal
mass and osteoporosis (Heaney et al. 1978; Raisz 1997).
Another example, compensatory hyperparathyroidism,
an unwanted consequence of chronic renal failure, can
enhance osteoclastic activity and OCS generation, fa-
voring bone resorption, which is characteristic of renal
osteodystrophy (Freitag et al. 1978). The evidence sug-
gests that OCS and antioxidants are involved in bone
remodeling, although we cannot establish whether reac-
tive species are the cause rather than the effect of the
bone metabolic changes observed in many skeletal con-
ditions and diseases.
More recently, many studies are supporting a role for
the gut and its microbiome in the regulation of bone
density and health. Direct modulation of the quantity of
bacteria present (through use of antibiotics), as well as
addition of bacterial substrates (prebiotics) and addition
of beneficial bacteria (probiotics) can affect measures of
bone health and calcium metabolism (reviewed in
McCabe L et al. (McCabe et al. 2015)). However, there
is still much to learn regarding our understanding of the
signaling pathways that link the microbiome and gut to
skeletal health. Future studies should be performed to
pinpoint the mechanisms by which the microbiome
regulates osteoblast and osteoclast activities.
In conclusion, oxidative stress is an important medi-
ator of bone loss since increased free radical production
overwhelms the natural antioxidants defense mecha-
nisms, subjecting individuals to hyperoxidant stress
and thus leading to osteoporosis or risk of hip fracture.
Administration of antioxidants might protect bones
from osteoporosis and help accelerating the healing of
fractured bones.
Role of oxidation in skin photoaging
Ageing is a multifactorial process characterized by
metabolic, functional, and esthetic changes resulting
from intrinsic genetically programmed processes and
from environmental extrinsic factors (Helfrich et al.
2008; Thorin-Trescases et al. 2010). Photoaging is
an accelerated form of ageing, specifically of the
skin, resulting from exposure to ultraviolet (UV)
light (Kligman 1989; Gilchrest 2013), causing the
formation of deep wrinkles, loss of skin tone, dry-
ness, elastic tissue clumping, pigmentary alteration,
and exaggerated bruising (Yaar and Gilchrest 2012).
Many of these clinical manifestations are a result of
UV-induced changes in the dermis, the predominant
target of UV radiation. Histopathological changes
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include alterations of elastin and the development of
actinic elastosis, a hallmark of photoaging (Kligman
1969; Lewis et al. 2004). Actinic elastosis is char-
acterized by an accumulation of elastotic material
composed of abnormal elastin in addition to loss of
fibrillar collagens and proteoglycans (Gilchrest
2013; El-Domyati et al. 2002; Sellheyer 2003;
Weihermann et al. 2016). The key biological mech-
anism by which sun exposure leads to photoaging is
the generation of reactive oxygen species (Gilchrest
2013; Yaar and Gilchrest 2012; Krutmann 2000).
In the skin, reactive oxygen species can have delete-
rious effects on DNA, proteins, and lipids, particularly
polyunsaturated fatty acids, leading to the formation of
lipid oxidation products (LPO) which may contribute to
dysfunction and skin damage (Vistoli et al. 2013). Ul-
traviolet A (UVA) is the largest source of reactive oxy-
gen species, including the (non-radical oxidant) singlet
oxygen (1O2) at the major contributor to photoaging.
The skin has inherent defenses against UV-induced free
radicals that include melanin, the pigment responsible
for skin color, and constitutional repair processes pres-
ent in damaged skin cells. Melanin is the first-line of
defense against DNA damage at the surface of the skin.
Pheomelanin, the melanin present in large quantities in
red-haired individuals, is less protective than eumelanin,
the melanin seen in blonde, brown, and black-haired
individuals. However, melanin alone cannot entirely
prevent skin damage even in those with very dark skin
color. A second category of defense is repair processes
which remove damaged biomolecules before they can
accumulate and alter cell metabolism.
Oxidative stress and subsequent tissue damage oc-
curs when these lines of defense are overwhelmed. This
point of saturation for the cell’s defense mechanisms
may differ depending on the individual skin type and
vulnerability (Battie et al. 2014; Rinnerthaler et al.
2015). Regardless, topical and oral antioxidants may
combat photoaging by disrupting the molecular process-
es that promote reactive oxygen species generation.
These antioxidant supplements are not FDA-regulated
and consistency in recommendation is lacking.
Structure of the skin
The skin is comprised of three main layers including the
epidermis, dermis, and subcutaneous fat. The epidermis
is the most superficial layer and is composed of stratified
squamous cells or keratinocytes in addition to
melanocytes and Langerhans cells, the immune cells
of the epidermis. The dermis can be found just beneath
the epidermis. This is the layer of the skin predominately
targeted by the process of photoaging. The dermis is a
flexible connective tissue network primarily comprised
of collagen and elastin fibers embedded in a ground
substance matrix that supports nerves, sensory recep-
tors, lymphatic channels, and vasculature (Robinson
2015). Collagen comprises the majority of the dermis
with collagen type I constituting 75% of this total. The
predominant role of collagen is to impart strength and
structure to the skin. Elastic fibers are synthesized by
fibroblasts and keratinocytes and comprise approxi-
mately 3% of the dermis. The primary role of elastic
fibers is to confer the skin with elasticity and resilience.
The third component of the dermis is the ground sub-
stance. This material fills the spaces between collagen
and elastin fibers and adds resilience to the skin. It is
comprised of glycosaminoglycans (hyaluronic acid and
dermatan sulfate) and glycoproteins (Robinson 2015).
UV-induced production of reactive oxygen species
Sunlight, the source of UV radiation, is divided into
three main types based on wavelength. UVC (200–
280 nm) is filtered by the ozone layer, UVB (280–
320 nm) is mainly absorbed by the epidermis, and
UVA (320–400 nm) deeply penetrates into the dermis.
Aside from the direct reaction of UVB photons with
DNA in the epidermis, an important consequence of
skin irradiation by UVR (mainly UVAwhich represents
more than 95% of solar radiation) is the generation of
reactive oxygen species. This relationship between UV
exposure and reactive oxygen species generation has
been demonstrated by in vivo studies using markers of
antioxidant activity such as ferritin. UVA exposure in-
creases ferritin expression in basal and suprabasal
keratinocytes in the epidermis and interstitial cells in
the dermis suggesting an increase in oxidative stress
induced by UVA exposure. Reactive oxygen species
generation results from interactions between UV pho-
tons and endogenous photosensitizers (porphyrins,
riboflavin, quinines, trans-urocanicacid) that become
excited and react with O2 to produce reactive oxygen
species such as superoxide anion radical(O2
·–) and hy-
droxyl radical (·OH) non-radicals such as singlet oxygen
(1O2) and hydrogen peroxide (H2O2) (Wenk et al. 2001;
Panich et al. 2016). The singlet oxygen anion induces
guanine moiety oxidation followed by structural
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rearrangement and 8-oxo-7,8-dihydroguanine (8-oxo-
G) and 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxo-
dG) formation, which are biochemical markers of
UVA-induced DNA damage (Panich et al. 2016). Pro-
tective pathways include both antioxidative and base
excision repair (BER) pathways, but these pathways
may become overwhelmed. In such instances, UVR-
induced reactive oxygen species can lead to photoaging
by varied mechanisms (Panich et al. 2016).
Skin photoaging pathophysiology
The skin is largely exposed to ambient UV-irradiation
placing it at high risk for photooxidative damage. Oxi-
dative stress leads to clinical signs of photoaging via a
variety of different molecular mechanisms that converge
on altered epidermal and dermal DNA, lipids, and pro-
teins (Table 1).
Clinical features of photoaging include deep wrin-
kling, dyspigmentation, sallowness, telangiectasia, lax-
ity, and a leathery appearance (Helfrich et al. 2008).
These clinical changes are the result of UV-induced
microscopic changes occurring across skin levels, but
predominantly at the level of the dermis. There are also
UV-induced mutations in keratinocytes and melano-
cytes and UV-induced apoptosis of the stem cells in
the basal layer of the epidermis in addition to the hair
bulge, which contributes to the clinical features of slow
wound healing and dyspigmentation (Gilchrest 2013).
Epidermal thickening or atrophy may also occur
(Beckman and Ames 1998).
In the dermis, there are a number of UV-induced
changes that eventuate in, among others, skin wrinkling
and loss of skin turgor and elasticity. Collagen degrada-
tion is accelerated with exposure to UV light. The
decline in collagen with age is due at least in part to
Table 1 Contrast in histologic appearance of intrinsic ageing vs. photoaging (El-Domyati et al. 2002; Bosset et al. 2003)
Intrinsic ageing Photoaging
Epidermal basal layer Single layer of cuboidal cells with 1
melanocyte per 5–10 basal keratinocytes
intermixed with Merkel cells
No apoptosis Apoptosis of epidermal basal keratinocytes
Cellular infiltrate One layer of CD1a + cells found in lower
epidermis
Decreased Langerhans cell numbers
Memory CD4+ T cells around superficial
dermal blood vessels
CD1a+ cells distributed in two superposed
layers in lower and mid-epidermis. CD1a+
cells more irregular and less dendritic
Increased number of CD1a+ and protein
S100 (PS100)+ dendritic cells
Increased mast cells and macrophages,
especially in areas of elastosis
Decreased Langerhans cell numbers
Increased CD4+ T cells after acute drop
in days following sun exposure
Epidermal thickness Minimal to no thinning: Approximately
0.1 mm (50–100 cell layers thick)
Atrophy/thickening
Dermal collagen Decreased: diminished synthesis and/or
increased degeneration (via abnormally
increased expression of MMPs in aged skin)
Decreased: diminished synthesis and increased
degeneration (via UV-induced up-regulation
of MMPs)
Fibroblasts Intact Apoptotic in the upper dermis
Elastic fibers Dark purple staining of elastic fibers. This
correlates with loss of elastic tissue primarily
in fine subepidermal elaunin network. In the
reticular dermis, the elastic network may be
irregularly thickened, fragmented, and
disorganized
Solar elastosis: loss of eosin staining with
resulting bluish color in upper dermis. This
correlates with increased deposition of
thickened, tangled, and granular amorphous
elastic structures
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the increased activity of matrix metalloproteinases
(MMPs), collagenase, 92 kd gelatinase, heme oxygen-
ase-1, superoxide dismutase-2, and stromelysin (Battie
et al. 2014). The activity of MMPs increases with expo-
sure to UV light, increasing the destruction of existing
collagen. There is also decreased production of de novo
collagen. In vitro models report the disappearance of
dermal fibroblasts in the upper part of the dermal equiv-
alent within 48 h following UVexposure via an apopto-
tic process (Battie et al. 2014). The progressive loss of
fibrillar collagen and collagen VII from the dermis leads
to a large decrease in volume and strength with resultant
wrinkling, easy bruising, and torpid wound healing
(Gilchrest 2013).
Elastosis, or the accumulation of partially degraded
elastin fibers in the dermis, is another hallmark of photo-
aging (Gilchrest 2013). This is the result of UV-induction
of destructive proteins such as lysosomal protease cathep-
sin K, the most potent of the elastin-degrading enzymes,
increases in deposits of lysozyme, and alternative splicing
(Gilchrest 2013). Lysozyme deposits on elastic fibers are
seen in sun-damaged regions with the number of
lysozyme-containing elastin fibers appearing to correlate
with the degree of sun damage. It has been reported that
lysozyme exerts its elastin-damaging effects by binding
to fibers and inhibiting the proteolytic degradation of
altered fibers by elastases (Battie et al. 2014). Thus, the
occurrence of elastosis results from a reduction in func-
tional elastin and an increase in non-functional elastin. In
addition, UV radiation may induce altered splicing and
expression of tropoelastin isoforms that contain exon
26A, which code for a highly lipophilic segment. These
isoforms may alter the structural and biological properties
of elastin and affect normal elastic fiber formation
(Weihermann et al. 2016).
Additional manifestations of UV-induced damage
include detrimental DNA deletions. On average, skin
cells exhibit some 4977 base pair deletions. In
photoaged individuals, this deletion is up to 10-fold
more prevalent. This compromises mitochondrial integ-
rity and energy production, and increases mitochondrial
superoxide production, which is believed to be related to
the clinical signs of photoaging (Gilchrest 2013).
The full extent of oxidative stress responses as expe-
rienced by different skin types remains unexplored, but
clinicalmanifestations suggest that mechanisms for dam-
age and repair may differ. Photoaging in more fair-
skinned patients manifests with deep wrinkles and in
darker-skinned patients manifests as dyspigmentation.
This may result from racial variation in individual and
aggregated melanosome distribution. For example, in
Asians, there is a mix of individual (about 60%) and
aggregated (about 40%) melanosomes that differs from
European skin in which aggregated melanosomes are the
majority at 85% (Battie et al. 2014). There appears to be
a difference in the quantity of UV-induced DNA muta-
tions in different skin tones with in vitro work demon-
strating an inverse relationship between skin color and
UV-induced skin response. There is a dose-dependent
accumulation of DNA damage, throughout the entire
epidermal layer and upper dermis of light, intermediate,
and tan skin tones. In brown and dark skin tones, how-
ever, DNA damage is detected exclusively in suprabasal
epidermal layers.
Although variations in oxidative stress by skin type
remain largely unexplored, the general mechanisms by
which UV-induced oxidative stress leads to clinical
signs of photoaging are more established. Oxidative
stress incurred by human skin fibroblasts after UVR
enhances expression of cell cycle inhibitors p16INK4A
and p53/p21WAF1/CIP1, which eventually result in
premature senescence of fibroblasts. These fibroblasts
are not only key for collagen production, but also func-
tion as a key component of the skin microenvironment.
This fibroblast dysfunction destabilizes the microenvi-
ronment vital for skin stem cells (Panich et al. 2016).
UV-induced overexpression of c-Myc is correlated with
depletion of epidermal stem cells, causing them to over
proliferate, move out of their niche, and differentiate
(Panich et al. 2016).
Reactive oxygen species also activate signaling path-
ways in resident fibroblasts such as growth factor recep-
tors, MAPK, or redox-sensitive transcription factors,
leading to secretion of metalloproteases that degrade the
proteins of extracellular matrix (ECM), including colla-
gen. Reactive oxygen species indirectly provoke DNA
oxidation and mutations, particularly the formation of 8
oxo-deoxyguanosine (8-oxo-dG) in guanine bases, which
may be involved in skin cancer development (Wenk et al.
2001; Wang 2011). Reactive oxygen species may also
activate the p53-p21 axis, Akt-MAPK, ATM pathways in
addition to the forkhead homeobox type O (FOXO)
transcription factors in various types of stem cells by
influencing telomere length, thus accelerating the ageing
process in skin cells (Panich et al. 2016). Furthermore,
UV-radiation results in activation of cell surface receptors
leading to the activation of MAP-kinase p38, c-Jun ami-
no-terminal kinase (JNK) and extracellular signal-
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regulated kinase (ERK) and the recruitment of c-Fos and
c-Jun. This leads to the expression of MMP 3 and 9 in
fibroblasts and keratinocytes (Rinnerthaler et al. 2015).
Activator protein (AP)-1 inhibits transforming growth
factor (TGF)-β responsible for collagen production and
up-regulates the level of MMPs responsible for collagen
degradation. AP-1 levels become elevated and remain
elevated for at least 24 h following UV radiation. During
this time frame,MMPs are up-regulated and collagen and
ECM damage ensues (Helfrich et al. 2008).
In addition to DNA, lipids are a predominant target of
the reactive oxygen species oxidative attack, particularly
polyunsaturated fatty acids (PUFA) that are present in
the plasma membranes of fibroblasts. PUFA oxidation
generates lipid oxidation products (LPO), including al-
dehydes such as 4-hydroxynonenal (HNE),
malondialdehyde (MDA), acrolein, all of which form
adducts on proteins, leading to progressive dysfunction
and accumulation as modified material (carbonyl stress)
(Vistoli et al. 2013). The role of carbonyl stress evoked
by LPO in skin ageing is not yet clarified. However,
aldehyde adducts (HNE-, acrolein-adducts) are detected
in the lower epidermis and in the dermis, and could
contribute to fibroblast dysfunction and ECMmodifica-
tion (Larroque-Cardoso et al. 2015).
Preventing or minimizing photoaging
Unlike the process of intrinsic ageing that cannot be
halted, steps may be taken to reduce the damage from
non-chronological factors. The cell has its own endog-
enous pathways to protect against oxidative damage.
This includes enzymatic antioxidants such as superox-
ide dismutase (SOD), catalase (CAT), glutathione per-
oxidase (GPx), glutathione reductase, and thioredoxin
reductase (Panich et al. 2016). Nuclear factor erythroid-
2 related factor 2 (Nrf2) has also been implicated as a
key regulator of redox homeostatic genes involved in
skin adaptation to oxidative stress, with its depletion
compromising the ability of a given cell to protect
against photo-oxidative damage (Panich et al. 2016).
When these pathways are functional and faced with
low-level oxidative stress, the redox balance is main-
tained. However, extrinsic exposures may overwhelm
endogenous protective mechanisms leading to oxidative
tissue damage and thus photoaging.
Supplemental topical and dietary antioxidants may
offset the damage caused by an overwhelmed antioxi-
dative system. Common examples of antioxidants
include vitamin C (ascorbic acid), vitamin E (alpha-
tocopherol), beta-carotenes, and a variety of phytochem-
icals, particularly polyphenols derived from plant-based
foods and herbal products. Given their mechanism of
action, however, effective antioxidants would need to
have a very high antioxidative capacity and reactivity, to
be present in extremely high concentrations, to be stable
in their final formulation, and (if topical) to be able to
penetrate the skin barrier (Wang et al. 2011).
Vitamin C is a common, water-soluble, antioxidant
found in the diet. It functions as a cofactor for many
enzymatic reactions including the crosslinking of colla-
gen. It also scavenges free radicals via donation of its
electron and formation of a comparatively inert radical.
It can then either be further reduced or can react further
to become dehydroascorbic acid. Vitamin Cmay also be
involved in a redox cycle that can re-reduce membrane-
bound Vitamin E after it has been oxidized in acting as a
chain-breaking antioxidant. Vitamin E is found in plant
oils and has the ability to stop ongoing lipid peroxida-
tion chain reactions via reduction of lipid peroxl radicals
to hydroperoxides. In this process, it is itself trans-
formed into a comparatively inert radical that may be
further detoxified by ascorbate or glutathione. Topical
application of vitamin E further works by decreasing
MMP-1 transcription levels and pyrimidine dimer pho-
toproduct formation (Rinnerthaler et al. 2015). Beta-
carotene, a precursor to vitamin A, also works by scav-
enging radicals and inhibiting lipooxygenases capable
of producing reactive oxygen species. The peroxyl rad-
ical is directly added to its backbone forming an epoxide
that is later decomposed (Rinnerthaler et al. 2015).
Protection from oxidatively induced damage is pri-
marily via application of a broad-spectrum sunscreen
with UVA and UVB protection. Particular emphasis for
photoaging is placed on UVA (320 to 400 nm) protec-
tion given its central role in cutaneous reactive oxygen
species production (Wang et al. 2011). UVB (290 to
320 nm) is characterized by superficial penetration and
is primarily responsible for sunburns and direct DNA
damage. While antioxidants do exist as standalone in-
gredients in oral and topical formulations, manufac-
turers have begun to include antioxidants in sunscreens
with the claim of added oxidative damage protection
(Wang et al. 2011). In theory, this provides two layers of
protection: a Bpassive^ layer and an Bactive^ layer. The
Bpassive^ layer is comprised of UV filters that absorb or
reflect UV rays and the Bactive^ layer is comprised of
antioxidants that neutralize any reactive oxygen species
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generated despite the passive layer. Whether such a
system works upon application to the skin is unknown.
Quantification of antioxidant effectiveness has many
limitations and varied assays exist for such purpose. The
technical application, uses, and limits of such assays
have been described elsewhere (Pinti et al. 2016). There
is no validated rating system or single assay used be-
tween and among products labeled as antioxidants and,
thus, the ability of a consumer to draw conclusions
about effectiveness is limited. A common assay is the
radical skin protection factor (RSF). This is an ex vivo
technique using porcine skin that directly measures
protection against UVA-induced free radical formation.
It is calculated from the ratio of free radicals in unpro-
tected skin to those in protected skin with the radicals
quantified using electron spin resonance (ESR) spec-
troscopy (Wang et al. 2011). The proportion of protec-
tion provided by antioxidants can be determined by the
antioxidant power (AP) which compares oxidation pro-
tection provided by antioxidants versus UV filters. The
AP value is generated in vitro utilizing an equation
comprised of the constant reduction amplitude, the
quantity of reduced free radicals, the characteristic
weight of the antioxidant product, and the reduction
time. The resulting value is expressed in antioxidative
units (AU) with ascorbic acid utilized as the standard
(Wang et al. 2011).
Wang et al. used AP to determine the benefit of
supplementing sunscreens with antioxidants and found
low to zero AP units in many of the evaluated sun-
screens indicating little additional protection from anti-
oxidant additives. Of the 12 products tested, five prod-
ucts had an RSF over 15 (range 16.5–27). Of these five,
the most common UV filters were octocrylene, titanium
dioxide, and butyl methoxydibenzoylmethane. Ten of
the 12 products had an antioxidant power of 0. Those
with any measureable antioxidant power had multiple
antioxidant additives and perhaps multiple combina-
tions may offer better antioxidant protection. (Wang
et al. 2011).
Clinical studies have demonstrated an ability of sun-
screens to minimize some features of photoaging. A
study of 35 adults demonstrated solar elastosis was sig-
nificantly decreased (p = 0.0001) by at least twice-daily
application of a sunscreen consisting of 7%
octylethoxycinnamate, 6% oxybenzone, and 5% octyl
salicylate over 2 years (Boyd et al. 1995). Another study
reported a highly photostable sunscreen (high UVA pro-
tection factor 22) was able to protect against multiple
cellular markers of photoaging, sunburn cells,
Langerhans cell depletion, cyclobutane pyrimidine dimer
formation, and p53 expression. Clinical signs of photo-
aging from baseline to the end of the trial were reduced
by 24% in the daily sunscreen group compared to the
discretionary sunscreen group (relative odds 0.76, 95%
confidence interval (0.59–0.98) (Young et al. 2016).
Stand-alone antioxidants have been studied within
various animal and human tissue models demonstrating
benefit in certain markers of reactive oxygen species
damage. However, the real life efficacy of these prod-
ucts may be dramatically different from those noted in
these studies largely due to study designs which do not
replicate real world conditions in regards to time and
location of application.
Photoaging is largely due to ultraviolet-induced re-
active oxygen species and is distinct from intrinsic age-
ing. Intrinsic ageing is characterized by skin thinning,
laxity, and fine wrinkling whereas photoaging is char-
acterized by dryness, dyschromia, telangiectasia, and
deep wrinkling. (Rui Yin and Hamblin 2015). UVA-
radiation is primarily responsible for photoaging due
to its deep penetration into the skin with effects on
collagen, elastin, and the extracellular matrix. Topical
and oral antioxidants have been utilized with the goal of
quenching reactive oxygen species, but whether such
products prevent photoaging in a clinically meaningful
way remains unknown. Given the large role of UVA in
photoaging, however, it is generally recommended that
efforts at prevention of photoaging should incorporate
use of a broad-spectrum sunscreen.
Cataracts
The cause of cataracts, which is when the lens of the eye
becomes clouded and impairs eyesight, stems from
many different sources, yet many of these sources in-
volve the unbalanced production of free radicals in
common. In the eye lens, free radicals target the poly-
unsaturated fatty acids and lens crystallin proteins lead-
ing to the initiation of cataracts (Thiagarajan and
Manikandan 2013). Studies examining whether dietary
antioxidants offer protective effects against cataracts are
promising, but generally show mixed results.
Vitamin C (ascorbic acid) has strong antioxidant
properties and has been shown to protect against DNA
damage by quelling oxidative stress. Yet, in the presence
of transition metals, vitamin C, paradoxically,
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contributes to DNA damage (Cai et al. 2001). Dietary
supplementation of vitamin C has been associated with
reduced risk of developing age-related cataracts
(Yoshida et al. 2007; Jacques and Chylack 1991;
Hankinson et al. 1992). Though its effectiveness is still
up for debate, as other long-term studies showed that
dietary supplementation of vitamin C had no effect on
cataract development (Christen et al. 2010). Moreover,
vitamin C has been shown to effectively protect against
certain types of cataracts such as nuclear cataracts, but
not others such as cortical or posterior subcapsular cat-
aracts (Tan et al. 2008).
Vitamin E is another dietary antioxidant, however
clinical trials have shown that dietary supplementation
of vitamin E did not prevent development or slow
progression of age-related cataracts (McNeil et al.
2004) or did vitamin A (Chasan-Taber et al. 1999).
Additionally, diet-derived carotenoids from fruits and
vegetables showed a modest effect in decreasing the
risk of cataracts over the course of an 8-year study
(Brown et al. 1999) and 12-year study (Chasan-Taber
et al. 1999). However, not all carotenoids confer protec-
tion against cataracts, only lutein and zeaxanthin had a
measurable effect in both studies.
Age-related macular degeneration
The APOE/cholesterol paradox of age-related macular
degeneration
Age-related macular degeneration (AMD) is a common,
complex disease that results from interplay of genetic
and environmental risk factors. Polymorphisms in the
complement factor H (CFH) and in Apolipoprotein E
(APOE) account for a large part of the genetic risks to
AMD (Swaroop et al. 2007). Age, smoking, and obesity
are the main environmental risk factors (Chakravarthy
et al. 2010). The presence of large drusen, sizeable
extracellular deposits of lipids and glycoproteins
(Farkas et al. 1971) in Bruch’s membrane (BM), are a
major risk factor for debilitating late AMD (Klein et al.
2004). Large drusen in the absence of vision loss is
therefore considered the defining feature of intermediate
AMD. Choroidal neovascularisation (wet AMD), or an
extending lesion of the retinal pigment epithelium
(RPE) and photoreceptors (geographic atrophy, GA)
characterize late AMD (Sarks 1976). Intermediate
AMD affects more than 150 million people worldwide
and 10 million patients suffer from late AMD (Wong
et al. 2014).
Yet, our understanding about complex interactions of
risk factors and AMD formation is relatively unknown.
Early and late forms of AMD show chronic, non-
resolving subretinal accumulation of mononuclear
phagocytes (MP) (Levy et al. 2015a; Combadiere et al.
2007; Sennlaub et al. 2013; Lad et al. 2015; Gupta et al.
2003). MPs include monocytes (Mo), resident macro-
phages (rMφ) such as microglial cells (MC), and
monocyte-derived inflammatory macrophages (iMφ)
that arise during inflammation (Nathan and Ding
2010). While acute MP infiltration likely helps resolve
large drusen (Klein et al. 2002; Smith et al. 2010), their
chronic infiltration contributes significantly to the path-
ogenesis, as it can cause considerable collateral damage
and fuel further inflammation (Nathan and Ding 2010).
MPs plays a critical role in pathological choroidal neo-
vascularisation (CNV) (Tsutsumi et al. 2003; Sakurai
et al. 2003) and photoreceptor degeneration
(Combadiere et al. 2007; Sennlaub et al. 2013; Rutar
et al. 2012; Suzuki et al. 2012; Kohno et al. 2013; Cruz-
Guilloty et al. 2013; Hu et al. 2015; Eandi et al. 2016) in
advanced AMD (Moore and Tabas 2011).
Large drusen and atherosclerotic lesions contain sim-
ilar extracellular proteins (e.g., vitronectin, complement
factors, and apolipoprotein E) and important amounts of
cholesterol and cholesterol esters (Moore and Tabas
2011; Pikuleva and Curcio 2014; Hageman and
Mullins 1999; Mullins et al. 2000; Curcio et al. 2001).
These observations and experimental data led to the
hypothesis that drusen lesions develop secondary to a
deficit in the reverse cholesterol transport (RCT) similar
to atherosclerotic plaques (Pikuleva and Curcio 2014;
Malek et al. 2005; Ong et al. 2001). The RCT pathway
directs excess cholesterol by high-density lipoproteins
(HDL) to the liver for elimination, to avoid toxic over-
load of cholesterol in peripheral cells. Similarly, in ath-
erosclerosis it is well established that low levels of HDL
and high levels of non-HDL cholesterol participate in
cholesterol accumulation and plaque formation (Moore
and Tabas 2011). Accordingly, APOE−/− mice have
extremely high lipid levels and massive amounts of
cholesterol-rich β-VLDL and spontaneously develop
atherosclerotic lesions (Meir and Leitersdorf 2004). In-
terestingly, macrophage APOE plays an important role
in preventing the plaque formation (Van Eck et al. 1997;
Fazio et al. 1997). APOE−/− mice also accumulate lipid
debris in BM proposed to be similar to drusen (Ong
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et al. 2001), supporting the hypothesis that deficient
RCT is also involved in drusen genesis.
The AMD paradox
Taken the similarities of large drusen and atherosclerotic
plaques, one might expect a similar deregulation of the
RCT with both diseases. Curiously, the reverse is the
case: high levels of HDL, protective against atheroscle-
rosis, are associated with AMD (Klein et al. 1993; Klein
et al. 1997; Klein et al. 2003; Delcourt et al. 2001; van
Leeuwen et al. 2004; Paun et al. 2015). A polymorphism
of the ABCA1, linked with low HDL and impaired
RCT, has been shown to be protective against advanced
AMD (Chen et al. 2010). APOA-I levels are elevated
(not decreased) in the vitreous (Koss et al. 2014) and
serum (Paun et al. 2015) of AMD patients. Most impor-
tantly, the APOE4-isoform, associated with decreased
APOE levels (Riddell et al. 2008; Bales et al. 2009;
Sullivan et al. 2011; Levy et al. 2015b) (see below)
and impaired reverse cholesterol transport (Heeren
et al. 2004; Mahley et al. 2009), protects against AMD
(McKay et al. 2011). In reference to the BFrench
paradox^ (that summarizes the apparently paradoxical
epidemiological observation that the frequency of ische-
mic heart diseases in France is relatively moderate de-
spite having a diet rich in cholesterol (Richard 1987)),
one might therefore speak of an BAMD-paradox^ de-
scribing the seemingly paradoxical association of
markers of enhanced RCTwith AMD, despite the obvi-
ous morphological and molecular similarities between
cholesterol-rich drusen and atherosclerotic lesions.
AMD and apolipoprotein E
APOE is expressed in the liver and is the main lipopro-
tein of the brain and the retina (Mahley and Rall 2000;
Anderson et al. 2001). It is strongly secreted by hepato-
cytes, but also in the RPE (Ishida et al. 2004) and in
mononuclear phagocytes (MPs), such as Mφs and MCs
(Levy et al. 2015a; Peri and Nusslein-Volhard 2008). As
mentioned above, APOE plays a major role in macro-
phage lipid efflux and RCT in conjunction with APOA-I
(Mahley et al. 2009; Mahley and Rall 2000; Peri and
Nusslein-Volhard 2008). APOE, APOA-I, and choles-
terol can also influence innate immunity. Cholesterol
crystals can activate the innate immunity receptor clus-
ter, formed by toll-like receptors (e.g., TLR2, TLR4)
and obligate co-receptors (such as CD14) that activate
Myd88, NFκB and induce inflammatory cytokines
(CCL2, IL-6, TNFα, etc.). APOE and APOA-I can also
bind and neutralize lipophilic TLR ligands (such as β-
amyloid and LPS) and inhibit the induction of inflam-
matory cytokines (Azzam and Fessler 2012). But an
excess of APOE and APOA-I can also activate the
TLR2-TLR4-CD14-dependent IIRC, in the absence of
extracellular ligands: Under physiological conditions,
the different components of the IIRC of Mφs are sepa-
rated from each other, as some elements cluster to
cholesterol-rich membrane domains called lipid rafts
(e.g., CD14) while others are located in the non-raft
plasma membrane (e.g., TLR2 and TLR4) (Pfeiffer
et al. 2001). IIRC ligands, such as bacterial lipopolysac-
charides, overcome this separation, as they bind to the
extracellular domains of both co-receptors (CD14 and
TLRs), bringing the receptors and their intracellular
domains closely together, which activates Myd88,
NFκB and induces the transcription of inflammatory
cytokines (Schmitz and Orso 2002). However, in the
absence of IIRC ligands, excessive APOA-I and/or
APOE can extract enough cholesterol from the lipid raft
to lift the physiological separation of the IIRC co-
receptors and trigger the intracellular signaling (Levy
et al. 2015a; Smoak et al. 2010). In sterile inflammation,
excessive APOA-I and APOE can thereby induce in-
flammatory cytokines such as IL-6 and CCL2 (Levy
et al. 2015a; Smoak et al. 2010).
In AMD, APOA-I levels are elevated in the vitreous
(Koss et al. 2014) and serum (Paun et al. 2015) and
APOE accumulates in drusen (Klaver et al. 1998) and is
strongly expressed by subretinal MPs (Levy et al.
2015a). In mice, we showed that subretinal MPs of
Cx3cr1GFP/GFP-mice that develop subretinal inflamma-
tion and cardinal features of AMD (Combadiere et al.
2007) express similar high levels of APOE (Levy et al.
2015a), but also IL-6 (Levy et al. 2015a) and CCL2
(Sennlaub et al. 2013). Increased levels of CCL2 and
IL6 are also observed in late AMD (Sennlaub et al.
2013; Jonas et al. 2010; Seddon et al. 2005; Chalam
et al. 2014).ApoE deletion inCx3cr1GFP/GFP-mice near-
ly completely prevented age- and stress-induced patho-
genic subretinal MP accumulation (Levy et al. 2015a).
Mechanistically, APOE-induced IL-6 release from MPs
represses RPE immune-suppression and prolongs
subretinal MP survival and accumulation (Levy et al.
2015a). Additionally, APOE-dependent increase of
CCL2 recruits pathogenic inflammatory CCR2+ mono-
cytes to the subretinal space (Sennlaub et al. 2013).
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Excessive APOE, and possibly APOA-I, can thereby
induce chronic, pathogenic MP accumulation due to
decreased MP elimination (IL-6) and increased MP
recruitment (CCL2).
In humans, the APOE gene has three common genet-
ic variants (APOE2, APOE3, and APOE4) that lead to
six possible diplotypes. APOE4, believed to be the
ancestral form (Raichlen and Alexander 2014), evolved
to APOE3, and APOE3 to APOE2 due to two polymor-
phisms (rs429358 and rs7412, respectively) that are
imbedded in a well-defined CpG island, and lead to
two cysteine-arginine interchanges at residues 112 and
158 (Yu et al. 2013). In most populations, APOE3 is
now the most common isoform (80% frequency) com-
pared to APOE4- (14% frequency) and APOE2-iso-
forms (6% frequency). The APOE isoforms are associ-
ated with several common, age-related diseases. Nota-
bly, the APOE4-allele is the most important genetic risk
factor for Alzheimer’s disease and a risk factor of ath-
erosclerosis, while APOE2 is protective for Alzheimer
disease and atherosclerosis (except if associated with
type III familial hyperlipiproteinemia) (Mahley et al.
2009; Herz and Beffert 2000; Davignon et al. 1988).
Curiously, the association with AMD is inversed:
APOE2-allele carriers are at increased risk for develop-
ing late AMD (OR = 1.83 for homozygote carriers),
while the APOE4-allele protects for AMD (OR = 0.72
per haplotype) compared to the most common APOE3-
allele recently confirmed in a worldwide study compris-
ing 20,000 subjects (McKay et al. 2011). This associa-
tion was found for both clinical forms of late AMD, but
not for early/intermediate AMD (Paun et al. 2015),
suggesting the APOE isoforms are not primarily impli-
cated in the lipid accumulation in drusen genesis. In-
deed, the targeted replacement mice expressing the hu-
man APOE4 (TRE4), and not APOE2 (TRE2), accu-
mulate most lipids in Bruchs membrane compared to
APOE3-expressing TRE3 mice (Malek et al. 2005),
although APOE4-allele plays a protective role in human
AMD (McKay et al. 2011). Similar, lipid deposits are
also observed in APOE−/− mice (Ong et al. 2001), but
AMD is associated with increased APOE immunoreac-
tivity (Levy et al. 2015a; Anderson et al. 2001; Klaver
et al. 1998) in the human disease. These results suggest
that the reasons for the association of the APOE iso-
forms with AMD are not due to a decreased capacity to
evacuate cholesterol from Bruchs membrane.
The APOE isoforms are also associated with differ-
ences in APOE abundance : APOE plasma
concentrations are significantly higher in homozygous
APOE2-diplotype carriers and lower in APOE4-carriers
compared to the APOE3 homozygous diplotype (E2/E2:
13.8 mg/dl; E3/E2: 7.3 mg/dl; E4/E2: 6.7; E3/E3:
5.5 mg/dl; E3/E4: 5 mg/dl; E4/E4: 4.4 mg/dl) (Smit
et al. 1988). The increased APOE concentrations asso-
ciated with the APOE2 isoform are likely due to its
decreased affinity for the LDL receptor and impaired
clearance (Mahley and Rall 2000), but also to increased
transcription in certain cell types (astrocytes and Mφs),
due to the loss of a CpG site present in the APOE3-
alleles (Levy et al. 2015b; Yu et al. 2013). APOE2-
carriers also display higher APOE concentrations in
cerebrospinal fluid, brain tissue, and the retina (Riddell
et al. 2008; Bales et al. 2009; Levy et al. 2015b).
Compared to the APOE3-allele, the APOE4-allele is
transcribed similarly in neurons, astrocytes, and Mφs
(Levy et al. 2015b; Yu et al. 2013), but its protein
concentration in plasma (see above), CSF, brain, and
retina are decreased (Riddell et al. 2008; Bales et al.
2009; Sullivan et al. 2011; Levy et al. 2015b). The
structural changes in the APOE4 protein also lead to
diminished association with HDL (Dong and
Weisgraber 1996) and impaired reverse cholesterol
transport (Heeren et al. 2004; Mahley et al. 2009).
Using the targeted replacement mice expressing the
human APOE isoforms (TRE2, TRE3, and TRE4), we
recently showed that the increased levels of APOE in
MPs of TRE2-mice, activates the IIRC and induces IL-6,
and CCL2 (Levy et al. 2015b) similar to Cx3cr1GFP/
GFP-mice (Levy et al. 2015a). As a consequence, TRE2-
mice develop subretinal MP accumulation, photorecep-
tor degeneration, and exaggerated choroidal neovascu-
larization akin to AMD (Levy et al. 2015b). In the
context of APOE-dependent subretinal inflammation
in Cx3cr1GFP/GFP-mice, the APOE4-allele led to dimin-
ished APOE tissue levels and CCL2 levels and
protected Cx3cr1GFP/GFP-mice against harmful
subretinal MP accumulation observed in Cx3cr1GFP/
GFPTRE3 mice (Levy et al. 2015b).
A possible pathogenic role of excessive cholesterol
extraction and IIRC activation in AMD is also supported
by the observation of increased APOA-I levels in AMD
patients (Paun et al. 2015; Koss et al. 2014), the protec-
tive effect of an ABCA1 polymorphism (associated with
possibly impaired RCT) (Chen et al. 2010), and clinical
studies showing that statins (that inhibit cholesterol
synthesis) can accelerate the progression to late AMD
(VanderBeek et al. 2013).
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Our study also sheds an interesting light on the
puzzling differences of the APOE isoform association
with AMD (McKay et al. 2011) and Alzheimer disease
(Mahley and Rall 2000), two major age-related neuro-
degenerative diseases: In Alzheimer disease, the
APOE4-allele is associated with greater β-amyloid bur-
den, possibly due to decreased APOE tissue concentra-
tions and reduced efficacy in clearance of β-amyloid
clearance via multiple pathways (Bales et al. 2009;
Mahley et al. 2009). Accordingly, Cx3cr1−/−mice that
express increased amounts of APOE in MPs, including
MCs (Levy et al. 2015a), are protected against beta-
amyloid deposition in Alzheimer disease mouse models
(Lee et al. 2010b).
While a lack of APOE and RCT might play a path-
ogenic role due to reduced efficacy of cholesterol andβ-
amyloid clearance in atherosclerosis (Mahley et al.
2009) and Alzheimer disease (Bales et al. 2009;
Mahley et al. 2009), excessive APOE and RCT might
be responsible for IIRC activation and chronic inflam-
mation in AMD. These fascinating differences might
help explain the APOE/cholesterol paradox of age-
related macular degeneration.
Conclusions
This review explores the phenomenon of paradoxical
relationships in biology, particularly as they relate to
ageing and the etiology and/or progression of age-
related diseases (Fig. 5).
Our particular focus is on the oxygen paradox as a
means of exploring the potential underlying mechanisms
responsible for the French paradox. We discuss adaptive
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Fig. 5 Paradoxical relationships in the oxygen paradox and age-
related, organ-based diseases. The figure points out just some of
the paradoxical relationships between substances (free radicals,
antioxidants) or gene products (RCAN1, HDL), oxygen itself,
sunlight, fatty foods, hypoxia and reperfusion, etc. at low versus
high concentrations, doses, or exposures that have been discussed
in this review, and common age-related diseases of major organs.
Please note that space limitations preclude a truly exhaustive
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homeostasis and how environmental signals, such as sub-
toxic, non-damaging levels of oxidants can trigger the
body’s defense mechanisms to confer protection against
further assaults. We also examine how the decline of
adaptive homeostasis associated with age brings with it
a decreased ability to respond to stress. This review also
discusses age-associated dysfunction in major human
organs where we explore several mechanisms of defense
and degeneration. The common theme in age-related
oxidative damage is an imbalance in the redox state,
accompanied with increased oxidative stress. For exam-
ple, in bones oxidative stress is a major mediator of bone
loss, as well as in the skin where reactive oxygen species
damage is responsible for photoaging. Similarly, neuro-
degenerative diseases and ocular degeneration also have
their roots in oxidatively generated damage.
The oxygen paradox, specifically the dangers of im-
balanced oxygen or oxygen radical levels is clearly
illustrated in the lungs and heart. In the lungs, the
oxygen paradox was clearly experienced during the
early development of treatments for ARDS-related hyp-
oxemia with high FIO2 volume ventilation used to try to
regain normoxemia. It was quickly found, however, that
a large influx of oxygen would often result in oxygen
toxicity and lead to worsening of the lung injury. A
balance was needed to find a Bsafe^ and low FIO2 level
that would result in an effective treatment of ARDS. In
the heart, the oxygen paradox is illustrated by the pa-
thology of myocardial ischemia where blood flow is
initially restricted, but then is quickly restored leading
to reperfusion injury. During and after reperfusion is a
time of considerable oxidative stress that leads to exten-
sive cellular damage. However, should a myocardial
infarction actually occur, treatment is most successful
if administered in the small-time window pre-reperfu-
sion. The detrimental reduction in available oxygen as a
result of myocardial ischemia followed by the toxicity of
high oxygen exposure after reperfusion is a prime (but
unfortunate) example of the oxygen paradox in action.
The potency of controlling redox balance is well
illustrated in the context of cancer. On one hand, cancer
cells increase reactive oxygen species and generate
DNA damage, malignant transformation, and metabolic
perturbations that provide the necessary resources for
growth. On the other hand, cancer cells increase antiox-
idant activity during cancer progression to protect from
excessive reactive oxygen species production, thus
avoiding a toxic threshold. Disrupting this balance has
been shown to have promising results in fighting certain
breast and ovarian cancers, where chemotherapies in-
volving high basal levels of reactive oxygen species
have shown clinical promise. Exercise regimens also
appear to initiate antioxidant mechanisms that may in-
hibit critical components essential to tumor growth.
Nevertheless, these potential remedies must be applied
cautiously because antioxidant supplementation has al-
so been found to protect and encourage the grown of
cancers. Identifying an individual’s redox status and
applying oxidation/reduction-based therapies may
1 day prove to be a useful approach in cancer treatment.
The treatment of many disease states and age-related
outcomes all have commonalities in restoring or main-
taining redox balance. Diet-derived antioxidants show
some promise in preventing certain types of cataracts,
while the contributing to bone health and repair. Exercise,
which stimulates cognitive and motor function, has been
shown to affect metabolism and, in turn, affect
neuroplasticity. The Oxygen Paradox is a story of imbal-
ance in the redox state, while the French Paradox is a
potential illustration of robust mechanisms that allow for
the maintenance of redox balance. This review highlights
the consequences of redox state imbalances that affect the
ageing process, as well as many age-related diseases.
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